Data / Research funding / Aging
Aging: 16,706 NIH awards ($28.4B) to 1,283 organizations
16,706 NIH awards ($28.4B) in the NIH spending category Aging, to 1,283 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 16,706 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| NIEHS - Lung Microbiome Promotes Emphysema by Activating Lung Innate Immunity | NIH | National Cancer Institute | 2021 to 2025 | $2,960,824,321 | August 31, 2025 | August 30, 2026 | BRISCOE, LYNN | reporter.nih.gov |
| Health and Retirement Study: Yrs 35-40 | NIH | National Institute on Aging | 2021 to 2025 | $142,220,153 | September 25, 1990 | December 31, 2029 | WEIR, DAVID R. | reporter.nih.gov |
| Alzheimer's Clinical Trials Consortium (ACTC) | NIH | National Institute on Aging | 2021 to 2025 | $119,771,576 | December 2, 2017 | August 31, 2028 | AISEN, PAUL S. | reporter.nih.gov |
| Alzheimer's Disease Neuroimaging Initiative (ADNI4) | NIH | National Institute on Aging | 2022 to 2025 | $95,332,786 | September 30, 2004 | July 31, 2028 | WEINER, MICHAEL W | reporter.nih.gov |
| Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS) | NIH | National Institute on Aging | 2021 to 2025 | $82,684,947 | September 30, 2020 | August 31, 2026 | HANDEN, BENJAMIN L | reporter.nih.gov |
| DIAN-TU Primary Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $79,373,454 | September 15, 2018 | May 31, 2026 | MCDADE, ERIC MARTIN | reporter.nih.gov |
| California National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $70,585,773 | May 1, 1997 | April 30, 2028 | ATKINSON, SIMON J. | reporter.nih.gov |
| Support for National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $70,297,738 | May 1, 1997 | April 30, 2029 | NAGEL, BONNIE J. | reporter.nih.gov |
| NIA AD/ADRD Health Care Systems Research Collaboratory | NIH | National Institute on Aging | 2021 to 2025 | $69,169,841 | September 1, 2019 | August 31, 2030 | MOR, VINCENT | reporter.nih.gov |
| Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project | NIH | National Institute on Aging | 2022 to 2025 | $66,521,567 | September 1, 2022 | August 31, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) | NIH | National Institute on Aging | 2021 to 2025 | $65,403,220 | July 15, 2002 | May 31, 2027 | FOROUD, TATIANA M. | reporter.nih.gov |
| The National Health and Aging Trends Study and National Study of Caregiving | NIH | National Institute on Aging | 2021 to 2025 | $65,386,641 | September 30, 2008 | March 31, 2029 | SCHRACK, JENNIFER ANN | reporter.nih.gov |
| The Alzheimer's Disease Tau Platform Clinical Trial | NIH | National Institute on Aging | 2023 to 2024 | $60,700,604 | September 21, 2023 | August 31, 2028 | BOXER, ADAM L. | reporter.nih.gov |
| ADRC Consortium for Clarity in ADRD Research Through Imaging | NIH | National Institute on Aging | 2023 to 2024 | $60,357,563 | September 15, 2023 | August 31, 2028 | JOHNSON, STERLING C | reporter.nih.gov |
| The Long Life Family Study | NIH | National Institute on Aging | 2021 to 2025 | $60,108,132 | August 15, 2019 | June 30, 2030 | PROVINCE, MICHAEL A. | reporter.nih.gov |
| ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2) | NIH | National Institute on Aging | 2021 to 2025 | $56,766,232 | September 15, 2019 | August 31, 2030 | BOEVE, BRADLEY F | reporter.nih.gov |
| Tulane National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $52,341,995 | May 9, 1997 | April 30, 2028 | HAMM, L LEE | reporter.nih.gov |
| DIAN-TU: Tau Next Generation Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $49,839,335 | September 15, 2020 | May 31, 2027 | BATEMAN, RANDALL J | reporter.nih.gov |
| A multimodal brain cell atlas and community resource of Alzheimer's disease and comorbid dementias. | NIH | National Institute on Aging | 2021 to 2025 | $48,445,852 | March 1, 2020 | August 31, 2030 | LEIN, ED | reporter.nih.gov |
| National Alzheimer's Coordinating Center | NIH | National Institute on Aging | 2021 to 2025 | $45,845,722 | June 15, 2021 | May 31, 2027 | STEPHENS, KARI A | reporter.nih.gov |
| IU/JAX/PITT MODEL-AD Center | NIH | National Institute on Aging | 2021 to 2025 | $45,129,948 | September 30, 2016 | August 31, 2027 | LAMB, BRUCE T | reporter.nih.gov |
| Longitudinal multicenter head-to-head harmonization of tau PET tracers | NIH | National Institute on Aging | 2021 to 2025 | $41,111,092 | September 1, 2021 | May 31, 2027 | PASCOAL, THARICK | reporter.nih.gov |
| UC Irvine MODEL-AD | NIH | National Institute on Aging | 2021 to 2025 | $40,119,354 | September 15, 2017 | August 31, 2027 | LAFERLA, FRANK M | reporter.nih.gov |
| Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 Months | NIH | National Institute on Aging | 2021 to 2025 | $39,702,286 | June 1, 2020 | May 31, 2027 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| Wisconsin longitudinal study: Initial lifetime's impact on Alzheimer's disease and related disorders (WLS-ILIAD) | NIH | National Institute on Aging | 2021 to 2025 | $39,317,019 | September 15, 2018 | February 29, 2028 | ASTHANA, SANJAY | reporter.nih.gov |
| Study of Muscle, Mobility and Aging: SOMMA2 | NIH | National Institute on Aging | 2021 to 2025 | $38,028,895 | June 15, 2018 | June 30, 2029 | CUMMINGS, STEVEN RON | reporter.nih.gov |
| Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium | NIH | National Institute on Aging | 2021 to 2025 | $37,497,984 | September 30, 2021 | August 31, 2026 | HOHMAN, TIMOTHY J | reporter.nih.gov |
| Cognitive training to reduce incidence of cognitive impairment in older adults | NIH | National Institute on Aging | 2021 to 2024 | $37,326,564 | February 1, 2021 | January 31, 2027 | O'BRIEN, JENNIFER LEE | reporter.nih.gov |
| Conduits: Mount Sinai Health System Translational Science Hub | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $37,137,629 | July 10, 2022 | June 30, 2027 | WRIGHT, ROSALIND J | reporter.nih.gov |
| THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE NHLBI FUNDING FROM THE WOMEN'S HEALTH INITIATIVE (WHI) - CLINICAL COORDINATING CENTER (CCC). | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $36,880,325 | February 1, 2021 | January 31, 2026 | ANDERSON, GARNET L. | reporter.nih.gov |
| Health and Aging Brain among Latino Elders (HABLE-AT(N)) Study | NIH | National Institute on Aging | 2021 to 2025 | $36,277,689 | August 1, 2020 | April 30, 2027 | O'BRYANT, SID E | reporter.nih.gov |
| Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study | NIH | National Institute on Aging | 2021 to 2024 | $36,190,244 | August 15, 2020 | May 31, 2025 | ABUSHAKRA, SUSAN | reporter.nih.gov |
| Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP) | NIH | National Institute on Aging | 2022 to 2025 | $35,910,792 | July 1, 2022 | June 30, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| The Neighborhoods Study: Contextual Disadvantage and Alzheimer’s Disease and Related Dementias (ADRD) | NIH | National Institute on Aging | 2021 to 2025 | $35,388,433 | March 1, 2021 | May 31, 2026 | KIND, AMY J. | reporter.nih.gov |
| The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $35,158,235 | February 15, 2021 | January 31, 2027 | LAH, JAMES J | reporter.nih.gov |
| Epidemiology of Diabetes Interventions and Complications (EDIC) Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $35,015,476 | September 22, 2011 | June 30, 2027 | GUBITOSI-KLUG, ROSE A | reporter.nih.gov |
| Combination anti-amyloid therapy for preclinical Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2024 | $34,903,050 | September 30, 2018 | May 31, 2025 | AISEN, PAUL S. | reporter.nih.gov |
| A Next Generation Data Infrastructure to Understand Disparities across the Life Course | NIH | National Institute on Aging | 2023 to 2025 | $34,372,705 | August 15, 2023 | July 31, 2028 | KAPTEYN, ARIE | reporter.nih.gov |
| Collaborative Study on the Genetics of Alcoholism (COGA). | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $34,320,125 | September 29, 1989 | August 31, 2029 | PORJESZ, BERNICE | reporter.nih.gov |
| Education and Cognitive Functioning in Later Life: The Nation’s High School Class of 1972 | NIH | National Institute on Aging | 2024 to 2025 | $32,776,590 | September 30, 2022 | July 31, 2027 | MULLER, CHANDRA L | reporter.nih.gov |
| The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age | NIH | National Institute on Aging | 2021 to 2024 | $32,071,511 | September 30, 2020 | February 28, 2025 | BROOKS, MARIA MORI | reporter.nih.gov |
| Early Onset AD Consortium - the LEAD Study (LEADS) | NIH | National Institute on Aging | 2021 to 2023 | $31,594,379 | September 30, 2018 | May 31, 2025 | APOSTOLOVA, LIANA G | reporter.nih.gov |
| IUSM TREAT-AD Center | NIH | National Institute on Aging | 2021 to 2025 | $31,208,587 | September 30, 2019 | November 30, 2029 | PALKOWITZ, ALAN D. | reporter.nih.gov |
| Phase II randomized controlled trial of benfotiamine in early Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $30,295,384 | July 15, 2022 | June 30, 2028 | GIBSON, GARY E | reporter.nih.gov |
| The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) | NIH | National Institute on Aging | 2024 to 2025 | $30,281,212 | August 15, 2024 | July 31, 2029 | BOXER, ADAM L. | reporter.nih.gov |
| COPD GENE - GENETIC EPIDEMIOLOGY OF COPD - TASK AREA A: YEAR 3 - AUGUST 10, 2025 - AUGUST 9, 2026 | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $29,553,568 | August 10, 2025 | August 9, 2026 | NEWMAN, LEE S | reporter.nih.gov |
| A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Dementia with Lewy Bodies | NIH | National Institute on Aging | 2021 to 2023 | $29,498,064 | May 15, 2021 | April 30, 2025 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| UniProt: A Protein Sequence and Function Resource for Biomedical Science | NIH | National Human Genome Research Institute | 2021 to 2025 | $29,053,046 | September 18, 2014 | May 31, 2027 | BATEMAN, ALEX | reporter.nih.gov |
| DEVELOPMENT AND MAINTENANCE OF A MULTIGENOTYPIC AGED MOUSE COLONY | NIH | National Institute on Drug Abuse | 2021 to 2025 | $28,785,849 | March 14, 2024 | March 13, 2025 | reporter.nih.gov | |
| Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial | NIH | National Institute on Aging | 2021 to 2025 | $28,784,116 | August 15, 2019 | April 30, 2027 | BRINTON, ROBERTA EILEEN | reporter.nih.gov |
| Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $28,395,368 | September 1, 2022 | August 31, 2027 | SILVA, AFONSO C | reporter.nih.gov |
| National Longitudinal Study of Adolescent to Adult Health (Add Health): Wave VI Core Project | NIH | National Institute on Aging | 2021 to 2025 | $28,336,705 | March 1, 2021 | December 31, 2026 | HUMMER, ROBERT A | reporter.nih.gov |
| Bridge Funding for Dominantly Inherited Alzheimer Network | NIH | National Institute on Aging | 2021 to 2025 | $27,724,157 | September 15, 2008 | June 30, 2026 | BATEMAN, RANDALL J | reporter.nih.gov |
| The INCLUDE Data Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $27,560,616 | September 26, 2020 | August 31, 2030 | RESNICK, ADAM CAIN | reporter.nih.gov |
| Childhood Cancer Survivorship Study | NIH | National Cancer Institute | 2021 to 2025 | $27,522,831 | July 20, 1993 | November 30, 2026 | ARMSTRONG, GREGORY | reporter.nih.gov |
| Physical Rehabilitation for Older Patients with Acute HFpEF-The REHAB-HFpEF Trial | NIH | National Institute on Aging | 2022 to 2025 | $26,596,811 | August 15, 2022 | July 31, 2028 | KITZMAN, DALANE W | reporter.nih.gov |
| API A4 Alzheimer's Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $26,251,396 | September 1, 2018 | November 30, 2025 | REIMAN, ERIC MICHAEL | reporter.nih.gov |
| EO14042 DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $25,277,032 | November 1, 2021 | October 31, 2026 | MENEZES, SUPRIYA | reporter.nih.gov |
| ASPirin in Reducing Events in the Elderly - eXTension | NIH | National Institute on Aging | 2021 to 2023 | $24,851,437 | July 15, 2019 | April 30, 2026 | MURRAY, ANNE M | reporter.nih.gov |
| US POINTER Neuroimaging Ancillary Study | NIH | National Institute on Aging | 2021 to 2025 | $24,762,483 | August 1, 2019 | March 31, 2027 | LANDAU, SUSAN M | reporter.nih.gov |
| Precision Monitoring and Assessment in the Framingham Study: Cognitive, MRI, Genetic and Biomarker Precursors of AD & Dementia | NIH | National Institute on Aging | 2021 to 2024 | $24,586,693 | September 15, 2020 | May 31, 2026 | FARRER, LINDSAY A. | reporter.nih.gov |
| Center without Walls for Imaging Proteinopathies with PET | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $24,457,384 | September 24, 2019 | July 31, 2029 | MACH, ROBERT H | reporter.nih.gov |
| Asian Cohort for Alzheimer's Disease (ACAD) | NIH | National Institute on Aging | 2023 to 2025 | $24,263,451 | July 1, 2023 | June 30, 2028 | WANG, LI-SAN | reporter.nih.gov |
| Metformin in Alzheimer's dementia Prevention (MAP) | NIH | National Institute on Aging | 2021 to 2025 | $24,224,790 | August 15, 2019 | April 30, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $23,837,604 | April 9, 2019 | September 30, 2026 | GANGE, STEPHEN J | reporter.nih.gov |
| Integrating Information about Aging Surveys: Novel Integration of Contextual Data to Study Late-Life Cognition and Alzheimer’s Disease and Related Dementia and Dementia Care | NIH | National Institute on Aging | 2021 to 2025 | $23,672,206 | May 1, 2007 | March 31, 2027 | LEE, JINKOOK | reporter.nih.gov |
| Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study | NIH | National Institute on Aging | 2021 to 2024 | $23,438,396 | May 15, 2019 | December 31, 2025 | SPERLING, REISA A. | reporter.nih.gov |
| Decoding the Multifactorial Etiology of Neural Network Dysfunction in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $23,431,388 | August 15, 2021 | July 31, 2027 | MUCKE, LENNART | reporter.nih.gov |
| SF Bay Area MACS/WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $23,128,905 | April 1, 2019 | September 30, 2026 | TIEN, PHYLLIS C | reporter.nih.gov |
| Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations | NIH | National Institute on Aging | 2023 to 2025 | $23,106,653 | August 15, 2023 | July 31, 2028 | DE ERAUSQUIN, GABRIEL ALEJANDRO | reporter.nih.gov |
| Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO) | NIH | National Institute on Aging | 2021 to 2025 | $23,099,141 | September 30, 2021 | August 31, 2027 | PERLS, THOMAS T | reporter.nih.gov |
| Los Angeles CRS for the MACS/WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $22,107,486 | April 15, 2019 | September 30, 2026 | MIMIAGA, MATTHEW JAMES | reporter.nih.gov |
| University of Pittsburgh MACS/WIHS CCS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,988,029 | April 1, 2019 | September 30, 2026 | RINALDO, CHARLES R | reporter.nih.gov |
| THE NIA GENETICS OF ALZHEIMER'S DISEASE DATA STORAGE SITE | NIH | National Institute on Aging | 2021 to 2025 | $21,982,300 | April 1, 2012 | April 30, 2027 | WANG, LI-SAN | reporter.nih.gov |
| UT Southwestern Medical Center Simmons Comprehensive Cancer Center | NIH | National Cancer Institute | 2021 to 2025 | $21,900,548 | September 1, 2010 | July 31, 2026 | ARTEAGA, CARLOS L | reporter.nih.gov |
| Wisconsin Registry for Alzheimer's Prevention | NIH | National Institute on Aging | 2023 to 2025 | $21,491,270 | June 1, 2023 | February 29, 2028 | JOHNSON, STERLING C | reporter.nih.gov |
| BRAIN CONNECTS: A Center for High-throughput Integrative Mouse Connectomics | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $21,489,807 | September 8, 2023 | August 31, 2028 | LICHTMAN, JEFF W | reporter.nih.gov |
| APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $21,355,638 | September 30, 2020 | March 31, 2027 | REIMAN, ERIC MICHAEL | reporter.nih.gov |
| Unraveling the earliest phases of vascular cognitive impairment and dementia using CADASIL--a monogenic form of small vessel cerebrovascular disease | NIH | National Institute on Aging | 2021 to 2025 | $21,188,740 | September 30, 2021 | August 31, 2027 | PAULSEN, JANE S | reporter.nih.gov |
| Penn Artificial Intelligence and Technology Collaboratory for Healthy Aging | NIH | National Institute on Aging | 2021 to 2025 | $21,174,898 | September 30, 2021 | May 31, 2027 | DEMIRIS, GEORGE | reporter.nih.gov |
| A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB) | NIH | National Institute on Aging | 2023 to 2025 | $21,072,036 | February 1, 2023 | January 31, 2026 | ALAM, JOHN | reporter.nih.gov |
| Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,023,937 | April 1, 2019 | September 30, 2026 | SHARMA, ANJALI | reporter.nih.gov |
| Delaware Clinical and Translational Research ACCEL Program | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $21,011,968 | September 25, 2013 | June 30, 2028 | HICKS, GREGORY E | reporter.nih.gov |
| Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,007,836 | April 1, 2019 | September 30, 2026 | MARGOLICK, JOSEPH B. | reporter.nih.gov |
| The Origins of Alzheimer Disease in African Americans | NIH | National Institute on Aging | 2022 to 2025 | $20,889,453 | September 15, 2022 | June 30, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| Alzheimer's Gut Microbiome Project | NIH | National Institute on Aging | 2021 to 2023 | $20,743,566 | September 15, 2019 | August 31, 2025 | KADDURAH-DAOUK, RIMA F | reporter.nih.gov |
| Frontotemporal Dementia: Genes, Images, and Emotions | NIH | National Institute on Aging | 2021 to 2025 | $20,694,825 | September 1, 2002 | April 30, 2028 | GORNO TEMPINI, MARIA LUISA | reporter.nih.gov |
| Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in Cohort of Oldest-Old | NIH | National Institute on Aging | 2022 to 2025 | $20,680,832 | September 15, 2017 | June 30, 2027 | WHITMER, RACHEL A | reporter.nih.gov |
| Additional Sequencing for the Alzheimer Disease Sequencing Project (ADSP) the Follow-Up Study (FUS), The Diverse Population Initiative | NIH | National Institute on Aging | 2022 to 2024 | $20,575,729 | September 1, 2022 | August 31, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| Alzheimer's Prevention Initiative ADAD Colombia Trial Program | NIH | National Institute on Aging | 2024 to 2025 | $20,406,409 | September 1, 2024 | August 31, 2029 | ALEXANDER, ROBERT C | reporter.nih.gov |
| Einstein Aging Study | NIH | National Institute on Aging | 2021 to 2024 | $20,102,748 | September 29, 1982 | March 31, 2028 | DERBY, CAROL A. | reporter.nih.gov |
| Massachusetts Alzheimer's Disease Research Center (MADRC) | NIH | National Institute on Aging | 2021 to 2025 | $19,915,545 | May 15, 2019 | March 31, 2029 | GOMEZ-ISLA, TERESA | reporter.nih.gov |
| National Institute on Aging Alzheimer's Disease Family-Based Study (NIA-AD FBS) | NIH | National Institute on Aging | 2021 to 2025 | $19,881,397 | August 1, 2017 | April 30, 2027 | MAYEUX, RICHARD P | reporter.nih.gov |
| Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $19,790,656 | April 10, 2019 | September 30, 2026 | WOLINSKY, STEVEN M | reporter.nih.gov |
| Baylor College of Medicine Cancer Center - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $19,034,443 | July 1, 2007 | June 30, 2030 | REDDY, PAVAN | reporter.nih.gov |
| UCSD Shiley-Marcos Alzheimer's Disease Research Center P30 | NIH | National Institute on Aging | 2021 to 2025 | $18,959,959 | May 1, 2019 | March 31, 2029 | BREWER, JAMES B | reporter.nih.gov |
| Third Coast Center for AIDS Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,823,279 | April 9, 2015 | July 31, 2030 | MUSTANSKI, BRIAN | reporter.nih.gov |
| Health, Aging and Dementia in South Africa: A Longitudinal Study (HAALSI) | NIH | National Institute on Aging | 2021 to 2025 | $18,706,904 | September 15, 2013 | May 31, 2028 | BERKMAN, LISA F | reporter.nih.gov |
| Mississippi Center for Clinical and Translational Research | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $18,674,548 | August 18, 2016 | July 31, 2026 | GRANGER, JOEY P. | reporter.nih.gov |
| Mayo Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $18,486,241 | July 1, 2019 | April 30, 2029 | BOEVE, BRADLEY F | reporter.nih.gov |
| BRAIN CONNECTS: Center for a pipeline of high throughput integrated volumetric electron microscopy for whole mouse brain connectomics | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $18,402,104 | September 1, 2023 | August 31, 2028 | MACARICO DA COSTA, NUNO | reporter.nih.gov |
| Lifecourse health, cerebral pathology and differences in dementia risk (KHANDLE Study) | NIH | National Institute on Aging | 2021 to 2025 | $18,022,067 | June 1, 2016 | February 28, 2027 | WHITMER, RACHEL A | reporter.nih.gov |
| Study of Latinos-Investigation of Neurocognitive Aging-Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $17,997,906 | May 15, 2022 | January 31, 2028 | GONZALEZ, HECTOR M | reporter.nih.gov |
| DEVELOPMENT AND MAINTENANCE OF A MULTIGENOTYPIC AGED MOUSE COLONY | NIH | National Institute on Drug Abuse | 2021 to 2025 | $17,756,449 | December 20, 2018 | January 19, 2020 | reporter.nih.gov | |
| Mount Sinai Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $17,735,870 | May 1, 2020 | March 31, 2030 | SANO, MARY | reporter.nih.gov |
| Aging eyes and aging brains in studying alzheimer's disease: Modern ophthalmic data collection in the adult changes in thought (ACT) study | NIH | National Institute on Aging | 2021 to 2024 | $17,711,217 | September 1, 2019 | August 31, 2029 | LEE, CECILIA SUNGMIN | reporter.nih.gov |
| Additional Sequencing for the Alzheimer's Disease Sequencing Project (ADSP) | NIH | National Institute on Aging | 2021 to 2024 | $17,661,924 | July 1, 2020 | June 30, 2026 | VANCE, JEFFERY MARVIN | reporter.nih.gov |
| Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $17,255,961 | June 15, 2020 | April 30, 2030 | SMALL, SCOTT A | reporter.nih.gov |
| Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD (Renewal) | NIH | National Institute on Aging | 2021 to 2025 | $17,112,209 | August 15, 2018 | May 31, 2029 | HUGHES, TIMOTHY M. | reporter.nih.gov |
| Offspring Study of Mechanisms for Racial Disparities in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $17,095,138 | September 1, 2016 | May 31, 2027 | MANLY, JENNIFER JAIE | reporter.nih.gov |
| NORTHWESTERN Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $17,093,229 | August 15, 2021 | June 30, 2026 | VASSAR, ROBERT J | reporter.nih.gov |
| Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias | NIH | National Institute on Aging | 2022 to 2025 | $17,073,728 | September 1, 2022 | June 30, 2027 | NORRIS, CHRISTOPHER MARK | reporter.nih.gov |
| Add Health Parent Study: A Biosocial Resource for the Study of Multigenerational Racial/Ethnic Disparities in Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) | NIH | National Institute on Aging | 2023 to 2025 | $17,039,516 | August 15, 2023 | April 30, 2028 | HARRIS, KATHLEEN MULLAN | reporter.nih.gov |
| Biomarkers of Cognitive Decline Among Normal Individuals: The Biocard Cohort | NIH | National Institute on Aging | 2021 to 2025 | $16,952,609 | July 1, 2009 | May 31, 2027 | ALBERT, MARILYN S. | reporter.nih.gov |
| TASK ORDER 4 FOR THE DEVELOPMENT AND MAINTENANCE OF A MULTIGENOTYPIC AGED MOUSE COLONY. | NIH | National Institute on Drug Abuse | 2022 to 2025 | $16,942,370 | September 30, 2025 | September 29, 2026 | reporter.nih.gov | |
| Goizueta Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $16,684,611 | July 15, 2020 | April 30, 2030 | LEVEY, ALLAN I | reporter.nih.gov |
| Diabetes and brain amyloid in middle aged Hispanics | NIH | National Institute on Aging | 2021 to 2025 | $16,383,484 | September 1, 2015 | May 31, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| Cognition & Hippocampal/Cortical Systems in Aging | NIH | National Institute on Aging | 2021 to 2025 | $16,383,227 | September 1, 1997 | March 31, 2027 | KNIERIM, JAMES J | reporter.nih.gov |
| National Social Life, Health, and Aging Project: Round 5 | NIH | National Institute on Aging | 2021 to 2025 | $16,330,170 | September 15, 2014 | April 30, 2029 | WAITE, LINDA J | reporter.nih.gov |
| University of Kansas Alzheimer's Disease Research Center (KU ADRC) | NIH | National Institute on Aging | 2021 to 2025 | $16,309,323 | August 15, 2021 | June 30, 2026 | SWERDLOW, RUSSELL H. | reporter.nih.gov |
| Understanding Cohort Effects on Stroke, VCID, and Cognition After Major Epidemiologic Transitions | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $16,244,011 | September 24, 2001 | August 31, 2026 | JUDD, SUZANNE E | reporter.nih.gov |
| National Longitudinal Study of Adolescent to Adult Health (Add Health): Wave VI Cognition and Early Risk Factors for Dementia Project | NIH | National Institute on Aging | 2021 to 2025 | $16,156,406 | January 15, 2021 | December 31, 2026 | HUMMER, ROBERT A | reporter.nih.gov |
| The Alzheimer's Disease Research Center at the University of California, Irvine | NIH | National Institute on Aging | 2021 to 2025 | $16,032,156 | June 15, 2020 | March 31, 2030 | LAFERLA, FRANK M | reporter.nih.gov |
| Alzheimer's Disease Genetics Consortium | NIH | National Institute on Aging | 2021 to 2024 | $15,948,152 | April 1, 2009 | March 31, 2026 | SCHELLENBERG, GERARD DAVID | reporter.nih.gov |
| Arizona Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $15,728,435 | September 5, 2021 | June 30, 2027 | LANGBAUM, JESSICA BROOKE | reporter.nih.gov |
| Educational and Early Life Predictors of Mild Cognitive Impairment: New Evidence about Mediators and Moderators from High School & Beyond | NIH | National Institute on Aging | 2021 to 2022 | $15,706,591 | May 15, 2019 | February 29, 2024 | WARREN, JOHN ROBERT | reporter.nih.gov |
| ARIC Neurocognitive Study (ARIC-NCS) Renewal | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $15,682,941 | July 7, 2010 | March 31, 2024 | CORESH, JOSEF | reporter.nih.gov |
| MACS/WIHS Combined Cohort Study: Cook County Clinical Research Site (CC_CRS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $15,678,563 | April 1, 2019 | September 30, 2026 | FRENCH, AUDREY | reporter.nih.gov |
| Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias | NIH | National Institute on Aging | 2021 to 2025 | $15,514,157 | September 30, 2021 | May 31, 2027 | ELLERBY, LISA M | reporter.nih.gov |
| Center for Pacific Innovations, Knowledge, and Opportunities (PIKO) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $15,507,862 | September 1, 2021 | July 31, 2027 | KAHOLOKULA, JOSEPH KEAWE'AIMOKU | reporter.nih.gov |
| Clarifying the Optimal Application of SLT Therapy (COAST) Trial | NIH | National Eye Institute | 2021 to 2024 | $15,288,624 | September 30, 2020 | August 31, 2025 | WISNIEWSKI, STEPHEN R | reporter.nih.gov |
| Immune signatures of vaccine responses in vulnerable populations | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,275,325 | July 12, 2010 | April 30, 2028 | MONTGOMERY, RUTH R | reporter.nih.gov |
| The VETSA Longitudinal Twin Study of Cognition and Aging (VETSA 4) | NIH | National Institute on Aging | 2021 to 2024 | $15,274,483 | September 1, 2015 | March 31, 2026 | PANIZZON, MATTHEW S | reporter.nih.gov |
| FSH - an Aging Hormone? | NIH | National Institute on Aging | 2021 to 2025 | $15,166,862 | February 1, 2019 | April 30, 2029 | ZAIDI, MONE | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE - CLINICAL COORDINATING CENTER: TASK AREA B - LONG LIFE STUDY VISIT 2 LIMITED HOME VISIT | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $15,096,788 | March 4, 2022 | March 3, 2024 | ANDERSON, GARNET | reporter.nih.gov |
| Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $15,081,381 | April 1, 2019 | September 30, 2026 | LAHIRI, CECILE DELILLE | reporter.nih.gov |
| The Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Trial (REACT-AF) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $14,978,926 | August 25, 2022 | July 31, 2029 | PASSMAN, ROD S | reporter.nih.gov |
| NIH NATIONAL BRAIN AND TISSUE REPOSITORY | NIH | National Institute on Drug Abuse | 2021 to 2025 | $14,799,056 | May 1, 2025 | October 31, 2025 | reporter.nih.gov | |
| Johns Hopkins University Trial Innovation Center | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $14,762,337 | July 5, 2023 | April 30, 2028 | HANLEY, DANIEL F | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) FIELD CENTER (FC) - TASK AREA D | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $14,739,138 | August 13, 2023 | August 12, 2025 | CARSON, APRIL | reporter.nih.gov |
| English Longitudinal Study of Ageing - Renewal 2024 | NIH | National Institute on Aging | 2021 to 2025 | $14,720,227 | September 30, 2000 | May 31, 2029 | STEPTOE, ANDREW | reporter.nih.gov |
| Alzheimer's Disease Research Centers | NIH | National Institute on Aging | 2021 to 2025 | $14,719,450 | September 1, 2020 | March 31, 2030 | CHUI, HELENA CHANG | reporter.nih.gov |
| Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategies | NIH | National Institute on Aging | 2022 to 2025 | $14,689,794 | September 15, 2019 | December 31, 2026 | PERLS, THOMAS T | reporter.nih.gov |
| Causes and Consequences of Healthcare Inefficiency in Alzheimer’s Disease and Related Dementias | NIH | National Institute on Aging | 2021 to 2025 | $14,684,279 | August 1, 2001 | July 31, 2028 | BARNATO, AMBER E | reporter.nih.gov |
| Alzheimer's Disease Research Center - Administrative Supplement 2025 | NIH | National Institute on Aging | 2021 to 2025 | $14,671,380 | May 1, 2020 | April 30, 2026 | WISNIEWSKI, THOMAS M | reporter.nih.gov |
| Global Alzheimer's Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $14,626,193 | May 1, 2017 | April 30, 2024 | AISEN, PAUL S. | reporter.nih.gov |
| UAB-MISS MACS/WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,601,685 | April 1, 2019 | September 30, 2026 | KEMPF, MIRJAM-COLETTE | reporter.nih.gov |
| Advancing cross-disease comparisons through FAIR data practices to uncover shared molecular mechanisms between Alzheimer's disease and autoimmune disorders | NIH | National Institute on Aging | 2021 to 2025 | $14,514,376 | September 1, 2025 | April 30, 2027 | HEATH, LAURA MICHELLE | reporter.nih.gov |
| Integrative Pathways to Cognitive, Affective, and Brain Health | NIH | National Institute on Aging | 2022 to 2025 | $14,488,542 | September 30, 2022 | August 31, 2028 | RYFF, CAROL D. | reporter.nih.gov |
| Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease Biobanks | NIH | National Institute on Aging | 2021 to 2024 | $14,414,001 | September 15, 2020 | August 31, 2025 | THOMPSON, PAUL M | reporter.nih.gov |
| Surviving the HIV Epidemic (S/HE) in metropolitan Washington DC - Advancing knowledge through cohort studies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,413,637 | April 1, 2019 | September 30, 2026 | KASSAYE, SEBLE G | reporter.nih.gov |
| Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study | NIH | National Institute on Aging | 2022 to 2025 | $14,339,100 | August 15, 2022 | July 31, 2028 | DEAL, JENNIFER ANNE | reporter.nih.gov |
| Mild Cognitive Impairment: A Prospective Community Study | NIH | National Institute on Aging | 2021 to 2025 | $14,337,476 | September 1, 2005 | April 30, 2026 | GANGULI, MARY | reporter.nih.gov |
| National Social Life, Health, and Aging Project: Rounds 4.2 and 4.4 | NIH | National Institute on Aging | 2021 to 2025 | $14,285,263 | September 1, 2013 | February 28, 2027 | WAITE, LINDA J | reporter.nih.gov |
| The RADAR cohort study of multilevel Influences on HIV and substance use | NIH | National Institute on Drug Abuse | 2021 to 2025 | $14,251,651 | April 15, 2014 | April 30, 2030 | MUSTANSKI, BRIAN | reporter.nih.gov |
| Study of Healthy Aging in African Americans | NIH | National Institute on Aging | 2023 to 2025 | $14,240,222 | January 1, 2017 | May 31, 2028 | WHITMER, RACHEL A | reporter.nih.gov |
| The Mobile Toolbox for Monitoring Cognitive and Behavioral Function (MTB2) | NIH | National Institute on Aging | 2021 to 2024 | $14,206,304 | September 15, 2018 | May 31, 2029 | GERSHON, RICHARD | reporter.nih.gov |
| Education and Cognitive Functioning in Later Life: The Nation’s High School Class of 1972 | NIH | National Institute on Aging | 2022 to 2023 | $14,187,625 | September 30, 2022 | July 31, 2027 | MULLER, CHANDRA L | reporter.nih.gov |
| MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,117,524 | April 1, 2019 | September 30, 2026 | GUSTAFSON, DEBORAH R. | reporter.nih.gov |
| Vanderbilt Memory & Aging Project | NIH | National Institute on Aging | 2021 to 2025 | $14,019,775 | March 15, 2011 | March 31, 2027 | JEFFERSON, ANGELA L. | reporter.nih.gov |
| UNC MACS/WIHS Combined Cohort Study Clinical Research Site | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $13,957,792 | April 1, 2019 | September 30, 2026 | FLORIS-MOORE, MICHELLE | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) COORDINATING CENTER (CC) - TASK AREA D | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $13,919,988 | August 13, 2023 | August 12, 2025 | CARSON, APRIL | reporter.nih.gov |
| Extracellular Vesicles for Gaining Insights into Tissue Senescent Signatures: A SenNET Pilot and Exploratory Project | NIH | National Institute on Aging | 2021 to 2025 | $13,842,784 | September 30, 2021 | August 31, 2027 | KUCHEL, GEORGE A | reporter.nih.gov |
| Multicultural Community Dementia Screening | NIH | National Institute on Aging | 2021 to 2025 | $13,797,203 | May 1, 2021 | January 31, 2027 | GALVIN, JAMES E | reporter.nih.gov |
| Cognitive Neuroscience of Development and Aging (CoNDA) Center | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $13,774,095 | March 15, 2020 | May 31, 2030 | DUNAEVSKY, ANNA | reporter.nih.gov |
| Wyoming Sensory Biology COBRE | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $13,747,906 | September 1, 2017 | July 31, 2027 | SUN, QIAN-QUAN | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - COORDINATING CENTER - TASK AREA B.2 AND B.3 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $13,712,636 | November 15, 2024 | September 30, 2025 | COUPER, DAVID | reporter.nih.gov |
| A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Phase II Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Mild to Moderate Alzheimerʼs Disease | NIH | National Institute on Aging | 2021 | $13,634,548 | September 15, 2018 | May 31, 2024 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| Center for the Study of Aphasia Recovery (C-STAR) | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $13,541,079 | April 1, 2016 | March 31, 2027 | FRIDRIKSSON, JULIUS | reporter.nih.gov |
| Lysosome Regulation and Signaling in Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $13,495,371 | June 1, 2021 | February 28, 2027 | ZHENG, HUI | reporter.nih.gov |
| 1Florida Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $13,348,245 | June 15, 2020 | April 30, 2027 | SMITH, GLENN E. | reporter.nih.gov |
| Epidemiological and Genetic Investigations of Blood-Based Biomarkers for Alzheimer's Disease in the Multiethnic, Washington Heights, Inwood, Columbia Aging Project (WHICAP) | NIH | National Institute on Aging | 2021 to 2025 | $13,310,071 | June 1, 2021 | March 31, 2027 | MAYEUX, RICHARD P | reporter.nih.gov |
| ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028 | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $13,305,831 | July 7, 2010 | March 31, 2029 | CORESH, JOSEF | reporter.nih.gov |
| Prevention of Fractures in Patients with Parkinson's Disease | NIH | National Institute on Aging | 2022 to 2024 | $13,269,734 | September 30, 2018 | February 28, 2026 | CUMMINGS, STEVEN RON | reporter.nih.gov |
| MIND DIET AND DEMENTIA PREVENTION IN ISCHEMIC STROKE PATIENTS | NIH | National Institute on Aging | 2021 to 2025 | $13,186,351 | September 1, 2020 | May 31, 2027 | AGGARWAL, NEELUM T. | reporter.nih.gov |
| Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Surveys in India (LASI) | NIH | National Institute on Aging | 2021 to 2025 | $13,167,007 | September 15, 2015 | April 30, 2026 | LEE, JINKOOK | reporter.nih.gov |
| Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) | NIH | National Center for Advancing Translational Sciences | 2021 to 2024 | $13,154,158 | August 28, 2015 | March 31, 2026 | VERBALIS, JOSEPH G | reporter.nih.gov |
| The Dog Aging Project: Genetic and Environmental Determinants of Healthy Aging in Companion Dogs | NIH | National Institute on Aging | 2021 to 2023 | $12,999,051 | September 1, 2018 | December 31, 2024 | KEENE, CHRISTOPHER DIRK | reporter.nih.gov |
| MACS/WIHS -CCS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $12,990,830 | April 1, 2019 | September 30, 2026 | ALCAIDE, MARIA LUISA | reporter.nih.gov |
| Plasma brain-derived tau: a novel Alzheimer’s disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in blood | NIH | National Institute on Aging | 2023 to 2025 | $12,972,426 | September 1, 2023 | May 31, 2028 | KARIKARI, THOMAS K | reporter.nih.gov |
| The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2023 | $12,937,549 | August 15, 2016 | April 30, 2024 | SPERLING, REISA A. | reporter.nih.gov |
| The Duke Senescent Cell Evaluations in Normal Tissues (SCENT) Mapping Center | NIH | National Institute on Aging | 2021 to 2025 | $12,705,171 | September 30, 2021 | August 31, 2026 | NIXON, ANDREW B. | reporter.nih.gov |
| Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | NIH | National Institute on Aging | 2022 to 2025 | $12,690,286 | April 15, 2017 | April 30, 2027 | KAPLAN, HILLARD S | reporter.nih.gov |
| Health and Well-being Over the Life Course and Across Multiple Generations | NIH | National Institute on Aging | 2021 to 2025 | $12,637,970 | September 1, 2011 | February 5, 2026 | FRIEDMAN, ESTHER M. | reporter.nih.gov |
| Medicare at a Crossroads | NIH | National Institute on Aging | 2021 to 2025 | $12,593,170 | August 15, 2009 | April 30, 2030 | LANDON, BRUCE E. | reporter.nih.gov |
| A Randomized, Double-Blind, Placebo-Controlled Study of LHP588 in Subjects with P. gingivalis-Positive Alzheimer's Disease | NIH | National Institute on Aging | 2025 | $12,591,952 | August 15, 2025 | July 31, 2029 | DETKE, MICHAEL J. | reporter.nih.gov |
| Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of T3D-959 in Mild to Moderate Alzheimer's Disease Subjects | NIH | National Institute on Aging | 2021 to 2022 | $12,573,346 | May 1, 2019 | February 28, 2023 | DIDSBURY, JOHN | reporter.nih.gov |
| Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $12,536,106 | February 15, 2022 | November 30, 2026 | MURRAY, MELISSA ERIN | reporter.nih.gov |
| Center for Addiction and Disease Risk Exacerbation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $12,487,946 | August 1, 2019 | July 31, 2029 | MONTI, PETER M. | reporter.nih.gov |
| The BCM Knockout Mouse Production and Phenotyping Project (BCM KOMP2) | NIH | National Human Genome Research Institute | 2021 to 2025 | $12,471,307 | September 16, 2011 | June 30, 2027 | HEANEY, JASON D. | reporter.nih.gov |
| Impacts of receiving Alzheimer's disease genetic risk information among Latinos in northern Manhattan | NIH | National Institute on Aging | 2021 to 2024 | $12,295,034 | February 15, 2020 | November 30, 2025 | OTTMAN, RUTH | reporter.nih.gov |
| AIDS Linked to the IntraVenous Experience (ALIVE) Study | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,226,379 | January 1, 2014 | May 31, 2030 | MEHTA, SHRUTI H | reporter.nih.gov |
| Trans-omics Integration of Multi-omics Studies for Osteoporosis | NIH | National Institute on Aging | 2021 to 2025 | $12,202,183 | September 15, 2017 | June 30, 2027 | DENG, HONG-WEN | reporter.nih.gov |
| Exploring Cognitive Aging Using Reference Ability Neural Networks | NIH | National Institute on Aging | 2021 to 2025 | $12,167,937 | September 1, 2011 | June 30, 2027 | STERN, YAAKOV | reporter.nih.gov |
| Long term fracture risk and change in peripheral bone in the oldest old men: The MrOS study | NIH | National Institute on Aging | 2021 to 2024 | $12,122,513 | September 30, 2020 | May 31, 2026 | CAWTHON, PEGGY MANNEN | reporter.nih.gov |
| Center for Research and Education on Aging and Technology Enhancement - CREATE | NIH | National Institute on Aging | 2022 to 2025 | $12,069,399 | June 15, 2022 | May 31, 2027 | CZAJA, SARA J | reporter.nih.gov |
| Beta1-selective blockade for prevention of postmenopausal bone loss: A randomized controlled trial | NIH | National Institute on Aging | 2021 to 2025 | $12,029,156 | January 1, 2021 | December 31, 2026 | KHOSLA, SUNDEEP | reporter.nih.gov |
| Alzheimers Disease Patient Registry (Administrative Supplement) | NIH | National Institute on Aging | 2021 to 2023 | $11,991,901 | September 30, 1986 | June 30, 2026 | PETERSEN, RONALD C | reporter.nih.gov |
| A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $11,962,900 | September 30, 2021 | July 31, 2027 | LUCIANO, MARK GREGORY | reporter.nih.gov |
| DIAN-TU: Next Generation Prevention Trial | NIH | National Institute on Aging | 2022 to 2023 | $11,960,034 | September 1, 2017 | May 31, 2024 | BATEMAN, RANDALL J | reporter.nih.gov |
| Human anti-viral immune responses in tissues and circulation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,930,741 | January 1, 2017 | February 28, 2027 | FARBER, DONNA L. | reporter.nih.gov |
| Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems. | NIH | National Institute on Aging | 2021 to 2025 | $11,898,685 | September 15, 2007 | May 31, 2029 | TRIVEDI, AMAL N. | reporter.nih.gov |
| I3C DECADE: Developmental Epidemiology of Childhood Cardiovascular Exposures and Alzheimer’s Dementia | NIH | National Institute on Aging | 2022 to 2025 | $11,889,015 | July 1, 2022 | April 30, 2028 | MACLEHOSE, RICHARD F | reporter.nih.gov |
| REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD | NIH | National Institute on Aging | 2024 to 2025 | $11,773,020 | January 1, 2024 | December 31, 2028 | ELY, E WESLEY | reporter.nih.gov |
| Center for Musculoskeletal Disease Research (CMDR) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,683,826 | February 16, 2018 | January 31, 2028 | O'BRIEN, CHARLES A | reporter.nih.gov |
| Cross Sectional and Longitudinal Racial Disparity in Molecular Biomarkers of Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2024 | $11,652,217 | June 1, 2020 | March 31, 2026 | XIONG, CHENGJIE | reporter.nih.gov |
| Scripps Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $11,650,904 | May 1, 2018 | June 30, 2023 | TOPOL, ERIC JEFFREY | reporter.nih.gov |
| West Virginia University Stroke COBRE | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $11,604,264 | September 8, 2014 | May 31, 2026 | DEVRIES, ANNE COURTNEY | reporter.nih.gov |
| Kynurenine accumulation drives loss of muscle and bone function with aging | NIH | National Institute on Aging | 2021 to 2025 | $11,563,609 | May 1, 2011 | May 31, 2027 | ISALES, CARLOS M. | reporter.nih.gov |
| Estrogens, Cardiometabolic Health, and Female Cognitive Aging | NIH | National Institute on Aging | 2022 to 2025 | $11,521,268 | March 1, 2022 | February 28, 2027 | DANIEL, JILL M | reporter.nih.gov |
| Mapping Cellular Resolution Connectopathies in Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $11,497,463 | May 15, 2022 | April 30, 2027 | DONG, HONG-WEI | reporter.nih.gov |
| Sleep in Neurocognitive Aging and Alzheimers Research (SANAR) | NIH | National Institute on Aging | 2021 to 2025 | $11,494,462 | February 1, 2021 | January 31, 2027 | RAMOS, ALBERTO RAFAEL | reporter.nih.gov |
| Impact of Neuroinflammation on AD Occurrence: A Bi-Generational Population Study | NIH | National Institute on Aging | 2021 to 2025 | $11,418,675 | September 1, 2021 | May 31, 2027 | RAJAN, KUMAR B. | reporter.nih.gov |
| Genomic Characterization of Alzheimer Disease Risk in Admixed Populations with Native American and Southern European Genetic Ancestry | NIH | National Institute on Aging | 2021 to 2025 | $11,411,820 | February 1, 2021 | January 31, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| GENETIC AND EPIDEMIOLOGICAL FACTORS FOR AGE-RELATED TRAITS AND DISEASES IN THE SARDINIAN POPULATION (SARDINIA5); PERIOD OF PERFORMANCE: JUNE 1, 2021 - | NIH | National Institute on Aging | 2021 | $11,408,934 | June 1, 2021 | May 31, 2026 | FIORILLO, EDOARDO | reporter.nih.gov |
| Racial Differences in Late-Life Cognitive decline and risk of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $11,402,108 | September 30, 2004 | May 31, 2027 | BARNES, LISA L | reporter.nih.gov |
| Complement Mediated Remodeling in Pulmonary Vascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $11,355,302 | August 1, 2020 | June 30, 2026 | STENMARK, KURT R. | reporter.nih.gov |
| Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline | NIH | National Institute on Aging | 2021 to 2024 | $11,354,079 | August 1, 2020 | July 31, 2025 | GUPTA, ADITI | reporter.nih.gov |
| Circuit-specific cell types in aging and Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $11,340,010 | June 1, 2022 | May 31, 2028 | LEE, KUO-FEN | reporter.nih.gov |
| Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil | NIH | National Institute on Aging | 2023 to 2025 | $11,334,713 | August 15, 2023 | July 31, 2028 | BENNETT, DAVID ALAN | reporter.nih.gov |
| Pre-Symptomatic Familial ALS (Pre-fALS) Study: From Prodrome and Biomarkers to ALS/FTD Prevention | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $11,282,768 | September 15, 2018 | July 31, 2029 | BENATAR, MICHAEL | reporter.nih.gov |
| The Longitudinal Course of Imaging Biomarkers in People At Risk for Alzheimer’s Disease | NIH | National Institute on Aging | 2022 to 2025 | $11,223,576 | August 15, 2004 | March 31, 2027 | JOHNSON, STERLING C | reporter.nih.gov |
| KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems Biology | NIH | National Institute on Aging | 2021 to 2025 | $11,202,386 | August 15, 2021 | July 31, 2027 | SAYKIN, ANDREW J | reporter.nih.gov |
| Cognitive and Neurobiological Approaches to Plasticity (CNAP) Center Phase 2 | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,111,453 | July 15, 2017 | May 31, 2027 | BAILEY, HEATHER | reporter.nih.gov |
| Administrative Supplement for the NCI P30 CCSG to extend partnerships with comprehensive cancer control coalitions to study implementation of evidence-based cancer control interventions | NIH | National Cancer Institute | 2021 | $11,079,774 | January 1, 1997 | March 31, 2022 | LYNCH, THOMAS JAMES | reporter.nih.gov |
| Cell-type-specific neural circuit connectomes in the mouse models of aging and Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $10,898,840 | May 15, 2022 | April 30, 2027 | XU, XIANGMIN | reporter.nih.gov |
| A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2023 | $10,874,349 | April 1, 2019 | June 30, 2025 | FELDMAN, HOWARD | reporter.nih.gov |
| Longitudinal Imaging Biomarkers of Prodromal DLB | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,821,041 | September 25, 2017 | August 31, 2027 | KANTARCI, KEJAL | reporter.nih.gov |
| Innervation of the knee and TMJ | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $10,814,779 | September 23, 2022 | August 31, 2027 | ALLEN, KYLE D | reporter.nih.gov |
| Blood amyloid, tau, and neurodegeneration biomarkers and prediction of clinical onset, cognitive decline, and dementia diagnosis | NIH | National Institute on Aging | 2024 to 2025 | $10,584,728 | September 30, 2008 | May 31, 2029 | BATEMAN, RANDALL J | reporter.nih.gov |
| Arterial Stiffness, Cognition, and Equol (ACE) | NIH | National Institute on Aging | 2022 to 2025 | $10,581,052 | February 15, 2022 | January 31, 2027 | SEKIKAWA, AKIRA | reporter.nih.gov |
| VCID Biomarkers Coordinating Center | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $10,493,954 | September 30, 2016 | June 30, 2027 | GREENBERG, STEVEN M | reporter.nih.gov |
| A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $10,487,739 | September 25, 2019 | August 31, 2025 | CAMPBELL, CLAUDIA MICHELLE | reporter.nih.gov |
| The INCLUDE Project Down Syndrome Biorepository (DS-Biorepository) | NIH | National Institute on Aging | 2024 to 2025 | $10,436,444 | September 30, 2024 | August 31, 2029 | ESPINOSA, JOAQUIN M. | reporter.nih.gov |
| Genetic variant-based drug discovery targeting conserved pathways of aging | NIH | National Institute on Aging | 2021 to 2025 | $10,414,630 | September 15, 2017 | August 31, 2028 | VIJG, JAN | reporter.nih.gov |
| Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA. | NIH | National Institute on Aging | 2022 to 2025 | $10,320,460 | February 15, 2022 | January 31, 2027 | AGADJANYAN, MICHAEL G | reporter.nih.gov |
| BRAIN-ICU-2 Study: Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction (Dementia) in ICU Survivors, 2nd Study | NIH | National Institute on Aging | 2021 to 2024 | $10,318,677 | April 15, 2019 | January 31, 2026 | ELY, E WESLEY | reporter.nih.gov |
| Alzheimer's Disease and Related Dementias (ADRD) prevalence in American Samoa | NIH | National Institute on Aging | 2022 to 2025 | $10,293,481 | September 30, 2022 | August 31, 2027 | TOFAEONO, VAATAUSILI T | reporter.nih.gov |
| NIH Health Care Systems Research Collaboratory-Coordinating Center (U24) | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $10,249,994 | September 22, 2022 | May 31, 2028 | HERNANDEZ, ADRIAN | reporter.nih.gov |
| Vermont Center for Cardiovascular and Brain Health | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $10,185,844 | August 6, 2020 | May 31, 2026 | CUSHMAN, MARY | reporter.nih.gov |
| ACTIVE MIND: An adaptive clinical trial of cognitive training to improve function and delay dementia | NIH | National Institute on Aging | 2022 to 2023 | $10,112,651 | September 1, 2022 | June 24, 2024 | O'BRIEN, JENNIFER LEE | reporter.nih.gov |
| Understanding and Improving Healthcare Decision-Making and Outcomes for People Living with Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2021 to 2025 | $10,060,993 | February 1, 1997 | August 31, 2029 | BAICKER, KATHERINE | reporter.nih.gov |
| Longitudinal Relationships Among Sleep, Cognition and Alzheimer's Disease Biomarkers: Discerning Causal Associations, Mediators and Susceptibility | NIH | National Institute on Aging | 2021 to 2024 | $9,901,034 | May 1, 2021 | February 28, 2026 | REDLINE, SUSAN S. | reporter.nih.gov |
| LifeâÂÂs end Benefits of CannaBidol and TetrahYdrocannabinol (LiBBY) Trial | NIH | National Institute on Aging | 2021 to 2022 | $9,892,823 | September 15, 2020 | April 30, 2026 | MINTZER, JACOBO | reporter.nih.gov |
| Gateway Exposome Coordinating Center (GECC) For AD/ADRD Research | NIH | National Institute on Aging | 2024 to 2025 | $9,887,007 | August 1, 2024 | July 31, 2029 | LEE, JINKOOK | reporter.nih.gov |
| Vanderbilt Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,726,538 | December 1, 1996 | March 31, 2027 | POWERS, ALVIN C | reporter.nih.gov |
| DEploying High ValuE LOngitudinal Population-Based dAta in Dementia Research (DEVELOP AD Research) | NIH | National Institute on Aging | 2021 to 2024 | $9,684,597 | September 30, 2020 | May 31, 2026 | MORRISON, R. SEAN | reporter.nih.gov |
| Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging) | NIH | National Institute on Aging | 2023 to 2025 | $9,673,461 | September 30, 2021 | August 31, 2027 | ROGALSKI, EMILY J | reporter.nih.gov |
| National Swine Resource and Research Center (NSRRC) Years 21-25 | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $9,635,041 | September 1, 2003 | July 31, 2028 | LEE, KIHO | reporter.nih.gov |
| TASK ORDER 1 - OCR PROJECT MANAGEMENT, DSMB AND CROMS-RELATED SUPPORT | NIH | National Institute on Drug Abuse | 2024 to 2025 | $9,613,167 | March 25, 2024 | March 24, 2026 | APPELMANS, ELINE | reporter.nih.gov |
| Collaborative Approach for Asian Americans, Native Hawaiians, and Pacific Islanders Research and Education (CARE) 2.0 | NIH | National Institute on Aging | 2023 to 2025 | $9,607,843 | August 1, 2023 | June 30, 2028 | PARK, VAN MY TA | reporter.nih.gov |
| Center for 3D Structure and Physics of the Genome | NIH | National Human Genome Research Institute | 2021 to 2024 | $9,564,360 | September 18, 2020 | June 30, 2026 | DEKKER, JOB | reporter.nih.gov |
| Determining the mechanism of pks+ E.coli-associated carcinogenesis in early onset colorectal cancer. | NIH | National Cancer Institute | 2022 to 2025 | $9,558,240 | September 20, 2022 | August 31, 2027 | O'REILLY, EILEEN MARY | reporter.nih.gov |
| Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid and Tau in Older Adults (IPAT-study) | NIH | National Institute on Aging | 2022 to 2025 | $9,488,371 | August 1, 2022 | July 31, 2027 | ZHANG, RONG | reporter.nih.gov |
| BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial | NIH | National Institute on Aging | 2021 to 2025 | $9,481,336 | February 15, 2021 | November 30, 2026 | HANLEY, DANIEL F | reporter.nih.gov |
| Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) | NIH | National Institute on Aging | 2025 | $9,466,491 | September 1, 2023 | August 31, 2028 | STONE, KATIE L | reporter.nih.gov |
| Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $9,439,774 | March 10, 2016 | June 30, 2027 | MILLS, KATHERINE TERESA | reporter.nih.gov |
| Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,418,230 | September 1, 2021 | August 31, 2026 | GOATE, ALISON M | reporter.nih.gov |
| TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2020 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2025, CLOSING OF THE PERIOD OF AVAILABI | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $9,377,344 | May 1, 2025 | October 31, 2025 | reporter.nih.gov | |
| Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Order | NIH | National Institute on Aging | 2021 to 2024 | $9,373,073 | June 1, 2020 | March 31, 2026 | MAYEUX, RICHARD P | reporter.nih.gov |
| The San Antonio Heart and Mind Study | NIH | National Institute on Aging | 2023 to 2025 | $9,286,743 | July 1, 2023 | March 31, 2029 | SATIZABAL, CLAUDIA L | reporter.nih.gov |
| Transitions from Impaired Respiratory Health to Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $9,270,202 | August 15, 2014 | July 31, 2029 | KALHAN, RAVI | reporter.nih.gov |
| African Americans Fighting Alzheimer’s in Midlife (AA-FAIM) | NIH | National Institute on Aging | 2021 to 2025 | $9,250,399 | August 1, 2016 | November 30, 2027 | GLEASON, CAREY E | reporter.nih.gov |
| Assessing the role of cerebrovascular brain injury and dysfunction in Alzheimer’s disease pathogenesis in the BEACoN Cohort | NIH | National Institute on Aging | 2021 to 2025 | $9,240,061 | August 1, 2017 | December 31, 2027 | YASSA, MICHAEL A | reporter.nih.gov |
| Cellular and Molecular Geroscience CoBRE: Phase 2 | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $9,179,387 | February 1, 2019 | May 31, 2030 | SONNTAG, WILLIAM EDMUND | reporter.nih.gov |
| The Care Ecosystem Response to COVID-19: Accelerating Research on Dementia Care that Meets the Needs of Caregivers and Persons with Dementia during COVID-19 | NIH | National Institute on Aging | 2022 to 2024 | $9,143,854 | June 15, 2022 | May 31, 2026 | POSSIN, KATHERINE LAUREL | reporter.nih.gov |
| Identification of TDP-43 Modifiers Through Single-Cell Transcriptional and Epigenomic Dissection of ALS and FTLD-MND | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,106,321 | September 29, 2021 | August 31, 2026 | DONNELLY, CHRISTOPHER JAMES | reporter.nih.gov |
| Center of Excellence in Environmental Toxicology | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $9,096,433 | April 1, 2006 | May 31, 2030 | PENNING, TREVOR M | reporter.nih.gov |
| Resilience and brain health of older adults | NIH | National Institute on Aging | 2021 to 2025 | $9,066,206 | August 15, 2021 | May 31, 2027 | LENZE, ERIC J | reporter.nih.gov |
| NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - CLINICAL SITE - Alzheimer's disease | NIH | National Institute of Mental Health | 2023 to 2025 | $9,005,480 | August 23, 2023 | August 22, 2026 | HADIJAH, VACTOR | reporter.nih.gov |
| Epidemiologic Study of Neural Reserve and Neurobiology of Aging | NIH | National Institute on Aging | 2021 to 2023 | $8,995,869 | September 30, 2001 | May 31, 2026 | BENNETT, DAVID ALAN | reporter.nih.gov |
| Center for Stress and Neural Regulation of Reproductive Aging Health Outcomes | NIH | National Institute on Aging | 2021 to 2025 | $8,986,759 | June 1, 2020 | August 31, 2030 | JOFFE, HADINE | reporter.nih.gov |
| FRAMINGHAM HEART STUDY (FHS), TASK AREA A - CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2025 | $8,894,939 | February 14, 2025 | February 13, 2026 | LLOYD-JONES, DONALD | reporter.nih.gov |
| Consequences of Incarceration on Health, Age-Related Conditions, and Risk Factors for ADRD | NIH | National Institute on Aging | 2024 to 2025 | $8,887,003 | August 15, 2024 | April 30, 2029 | TEPLIN, LINDA A | reporter.nih.gov |
| Interventions That Retard Mammalian Aging | NIH | National Institute on Aging | 2021 to 2025 | $8,876,368 | April 15, 2003 | May 31, 2029 | KORSTANJE, RONNY | reporter.nih.gov |
| Experimental and Clinical Studies of Presbyacusis Extension and Supplement | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $8,845,880 | July 1, 1997 | July 31, 2026 | DUBNO, JUDY R | reporter.nih.gov |
| Johns Hopkins-Tufts Trial Innovation Center HEAL Pain ERN Supplement | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $8,842,412 | July 1, 2016 | June 30, 2023 | HANLEY, DANIEL F | reporter.nih.gov |
| Coronary Artery Calcium and its Association with Protective/Risk Factors and Epigenetic Patterns in Diverse US Hispanic/Latino Adults | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $8,752,600 | June 1, 2021 | May 31, 2026 | DAVIGLUS, MARTHA L | reporter.nih.gov |
| Toward Next Generation Data on Health and Life Changes at Older Ages | NIH | National Institute on Aging | 2021 to 2022 | $8,740,462 | September 30, 2017 | June 30, 2023 | KAPTEYN, ARIE | reporter.nih.gov |
| Risk Factors, Pathology, and Clinical Expressions of AD | NIH | National Institute on Aging | 2021 to 2024 | $8,703,055 | July 15, 1998 | April 30, 2026 | BENNETT, DAVID ALAN | reporter.nih.gov |
| Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions | NIH | National Institute on Aging | 2021 to 2025 | $8,654,669 | July 1, 2021 | June 30, 2027 | TEMPLE, SALLY | reporter.nih.gov |
| Public Health and Autism Science advancing Effectual Strategies across the life course (PHASES) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $8,623,178 | September 6, 2022 | August 31, 2027 | ROBINS, DIANA L | reporter.nih.gov |
| Microbiome, Metabolites, and Alcohol in HIV to Reduce CVD (META HIV CVD) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $8,561,222 | September 10, 2021 | August 31, 2026 | FREIBERG, MATTHEW S | reporter.nih.gov |
| Educational and Early Life Predictors of Mild Cognitive Impairment: New Evidence about Mediators and Moderators from High School & Beyond | NIH | National Institute on Aging | 2023 to 2024 | $8,554,832 | May 15, 2019 | February 28, 2026 | WARREN, JOHN ROBERT | reporter.nih.gov |
| P-CARRS-BRAIN: Multi-domain (genetic, socio-behavioral, vascular) risk factors and prediction of Alzheimer’s Disease continuum in South Asians in India | NIH | National Institute on Aging | 2024 to 2025 | $8,548,820 | September 15, 2024 | August 31, 2029 | NARAYAN, KABAYAM M VENKAT | reporter.nih.gov |
| Clinical and Translational Science Award | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $8,548,346 | March 22, 2018 | April 30, 2023 | KELLER, MARLA J | reporter.nih.gov |
| Alzheimer variants: Propagation of shared functional changes across cellular networks | NIH | National Institute on Aging | 2021 to 2025 | $8,542,236 | July 15, 2021 | June 30, 2027 | DE JAGER, PHILIP L | reporter.nih.gov |
| The Aging Pituitary/Gonadal Axis | NIH | National Institute on Aging | 2021 to 2025 | $8,508,061 | April 15, 2009 | May 31, 2028 | BOUSFIELD, GEORGE R | reporter.nih.gov |
| Preserving Cognitive Resilience: A Biracial Parent-Offspring Study | NIH | National Institute on Aging | 2022 to 2024 | $8,461,054 | March 1, 2019 | May 31, 2026 | RAJAN, KUMAR B. | reporter.nih.gov |
| Atherosclerosis Intervention with Novel Tissue Selective Estrogen Complex Therapy | NIH | National Institute on Aging | 2021 to 2023 | $8,410,475 | March 1, 2019 | August 31, 2025 | HODIS, HOWARD NEIL | reporter.nih.gov |
| Rocky Mountain Cannabis Research Center | NIH | National Institute on Drug Abuse | 2023 to 2025 | $8,380,548 | September 1, 2023 | June 30, 2028 | HUTCHISON, KENT E. | reporter.nih.gov |
| Functional Genomic Dissection of Alzheimer's Disease in Humans and Drosophila Models | NIH | National Institute on Aging | 2021 to 2025 | $8,376,812 | July 1, 2021 | June 30, 2026 | SHULMAN, JOSHUA M | reporter.nih.gov |
| Genetic Architecture of Alzheimer’s disease Proteinopathies | NIH | National Institute on Aging | 2021 to 2024 | $8,376,544 | April 15, 2021 | February 28, 2026 | KAMBOH, M. ILYAS | reporter.nih.gov |
| Genetic Studies of Alzheimer's Disease in Jewish and Arab Populations | NIH | National Institute on Aging | 2023 to 2025 | $8,372,205 | September 1, 2023 | August 31, 2028 | FARRER, LINDSAY A. | reporter.nih.gov |
| Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $8,348,817 | September 15, 2022 | May 31, 2027 | ALBER, JESSICA | reporter.nih.gov |
| REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-4 (REGARDS-MI-4) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $8,345,645 | September 10, 2022 | July 31, 2027 | SAFFORD, MONIKA M | reporter.nih.gov |
| ASYMMETRIC NEURODEGENERATION AND LANGUAGE IN PRIMARY PROGRESSIVE APHASIA | NIH | National Institute on Aging | 2022 to 2025 | $8,306,361 | June 15, 2022 | March 31, 2027 | MESULAM, MAREK-MARSEL M | reporter.nih.gov |
| Multi-omic functional assessment of novel AD variants using high-throughput and single-cell technologies | NIH | National Institute on Aging | 2021 to 2025 | $8,305,058 | July 1, 2021 | June 30, 2026 | MONTINE, THOMAS J | reporter.nih.gov |
| Exceptional Longevity Data Management and Coordinating Center | NIH | National Institute on Aging | 2022 to 2025 | $8,296,806 | September 1, 2022 | July 31, 2027 | VARMA, SUSHEEL | reporter.nih.gov |
| A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $8,293,749 | September 30, 2021 | August 31, 2026 | ZAIDI, MONE | reporter.nih.gov |
| Gulf Coast Center for Precision Environmental Health | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $8,275,327 | May 15, 2019 | May 31, 2029 | WALKER, CHERYL L. | reporter.nih.gov |
| Boston OAIC: A Translational Approach to Function Promoting Therapies | NIH | National Institute on Aging | 2021 to 2025 | $8,257,493 | September 1, 2008 | June 30, 2027 | BHASIN, SHALENDER | reporter.nih.gov |
| Center of Biomedical Research Excellence in Matrix Biology Phase II | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $8,248,947 | August 1, 2014 | May 31, 2025 | OXFORD, JULIA THOM | reporter.nih.gov |
| Manufacturing of Drug Product, Dual Aβ/tau Vaccine for Clinical Trials | NIH | National Institute on Aging | 2021 to 2023 | $8,244,109 | February 1, 2019 | January 31, 2025 | AGADJANYAN, MICHAEL G | reporter.nih.gov |
| The Physical Biology of Neurodegeneration in Sporadic Amyotrophic Lateral Sclerosis/Frontotemporal Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $8,227,499 | September 1, 2021 | August 31, 2027 | PHATNANI, HEMALI | reporter.nih.gov |
| COBRE in Stroke Recovery Administrative Supplement - Team Science | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $8,212,817 | June 2, 2014 | March 31, 2025 | KAUTZ, STEVEN A. | reporter.nih.gov |
| GLASS-AD: Global Latinos Sequencing Study for Alzheimer's Disease | NIH | National Institute on Aging | 2023 to 2025 | $8,212,071 | September 30, 2023 | August 31, 2028 | TOSTO, GIUSEPPE | reporter.nih.gov |
| Race / Ethncicity, Hypertension and Prevention of VCID and Stroke after Intracerebral Hemmorrhage | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $8,210,604 | February 1, 2016 | July 31, 2027 | ROSAND, JONATHAN | reporter.nih.gov |
| Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $8,189,971 | September 15, 2024 | August 31, 2026 | GITLER, AARON D. | reporter.nih.gov |
| Emergency General Surgery Delirium Recovery Model: A Collaborative Care Intervention | NIH | National Institute on Aging | 2022 to 2025 | $8,173,947 | July 1, 2022 | June 30, 2027 | ZARZAUR, BEN L | reporter.nih.gov |
| Disordered Proteostasis as a Driver of Disease in the Aging Lung | NIH | National Institute on Aging | 2021 to 2024 | $8,161,610 | July 1, 2015 | March 31, 2025 | BUDINGER, GR SCOTT | reporter.nih.gov |
| A deep longitudinal analysis of next generation influenza vaccines in older adults | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $8,127,184 | January 1, 2022 | December 31, 2026 | UCAR, DUYGU | reporter.nih.gov |
| Alzheimer's Prevention Initiative ADAD Colombia Trial | NIH | National Institute on Aging | 2021 to 2022 | $8,118,116 | April 1, 2017 | September 30, 2024 | REIMAN, ERIC MICHAEL | reporter.nih.gov |
| Racial/Ethnic Disparities in ADRD Risk: The Impact of Social Relations | NIH | National Institute on Aging | 2021 to 2024 | $8,105,276 | June 1, 2020 | March 31, 2026 | ANTONUCCI, TONI CLAUDETTE | reporter.nih.gov |
| Characterizing the Genetic Risk for Alzheimer Disease in African and Admixed African-American Ancestries | NIH | National Institute on Aging | 2024 to 2025 | $8,032,655 | September 30, 2024 | August 31, 2029 | GRISWOLD, ANTHONY JOHN | reporter.nih.gov |
| Comprehensive functional phenotyping of trigeminal neurons innervating temporomandibular joint (TMJ) tissues in male female and aged mice primates and humans with and without TMJ disorders (TMJD) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $8,002,252 | September 23, 2022 | August 31, 2027 | AKOPIAN, ARMEN N | reporter.nih.gov |
| Addressing Alzheimer's Disease and Related Dementias Disparities: The American Indigenous Cognitive Assessment (AMICA) Project | NIH | National Institute on Aging | 2022 to 2025 | $7,983,648 | June 1, 2022 | May 31, 2027 | JACKLIN, KRISTEN | reporter.nih.gov |
| CHARTER Plus: A resource for cutting-edge research on neurological function and mental health in people with HIV and substance use disorders across the lifespan | NIH | National Institute of Mental Health | 2022 to 2025 | $7,973,681 | February 1, 2022 | November 30, 2026 | LETENDRE, SCOTT L | reporter.nih.gov |
| Sex Differences in Major Depression: Impact of Prenatal Stress-Immune and Autonomic Dysregulation | NIH | National Institute of Mental Health | 2021 to 2024 | $7,968,668 | February 1, 2020 | April 24, 2025 | GOLDSTEIN, JILL M | reporter.nih.gov |
| Indiana Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,959,091 | July 6, 2015 | May 31, 2030 | EVANS-MOLINA, CARMELLA | reporter.nih.gov |
| THE NIH PRECISION BRAIN HEALTH NETWORK: Open and Inclusive Measurement of Neuropsychological Change for AD/ADRD Primary Prevention Trials | NIH | National Institute on Aging | 2025 | $7,948,867 | August 1, 2025 | July 31, 2030 | SLIWINSKI, MARTIN J | reporter.nih.gov |
| Communication Bridge: Optimizing an evidence-based intervention for individuals with primary progressive aphasia | NIH | National Institute on Aging | 2023 to 2025 | $7,878,167 | September 15, 2017 | August 31, 2028 | ROGALSKI, EMILY J | reporter.nih.gov |
| Higher Order Chromatin and Genetic Risk for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $7,828,464 | September 1, 2015 | May 31, 2027 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Claude D. Pepper Older Americans Independence Center at Yale | NIH | National Institute on Aging | 2021 to 2025 | $7,769,010 | September 30, 2002 | June 30, 2028 | GILL, THOMAS MICHAEL | reporter.nih.gov |
| ERICH-GENE | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $7,768,356 | August 1, 2010 | June 30, 2025 | DEMEL, STACIE | reporter.nih.gov |
| The POINTER Neurovascular Ancillary Study | NIH | National Institute on Aging | 2021 to 2024 | $7,761,498 | April 15, 2020 | December 31, 2025 | BRINKLEY, TINA E | reporter.nih.gov |
| Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2021 to 2025 | $7,757,977 | July 1, 2021 | June 30, 2027 | KAYED, RAKEZ | reporter.nih.gov |
| Mapping the vulnerable locus coeruleus pathways in aging and AD | NIH | National Institute on Aging | 2022 to 2025 | $7,731,727 | August 15, 2022 | July 31, 2027 | CHUNG, KWANGHUN | reporter.nih.gov |
| CureGN | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,684,480 | September 16, 2013 | May 31, 2029 | MARIANI, LAURA H | reporter.nih.gov |
| Center for Testing Potential Anti-Aging Interventions | NIH | National Institute on Aging | 2021 to 2025 | $7,623,448 | April 15, 2004 | May 31, 2029 | SALMON, ADAM | reporter.nih.gov |
| SCAN: Standardized Centralized Alzheimer's and Related Dementias Neuroimaging | NIH | National Institute on Aging | 2021 to 2025 | $7,600,838 | May 1, 2020 | April 30, 2027 | JAGUST, WILLIAM J. | reporter.nih.gov |
| Vietnamese Insights into Cognitive Aging Program (VIP) | NIH | National Institute on Aging | 2021 to 2025 | $7,598,841 | February 15, 2021 | May 31, 2026 | MEYER, OANH L | reporter.nih.gov |
| Look AHEAD Sleep: Sleep-disordered breathing, circadian rest/activity rhythms, and the risk of Alzheimer's disease and related dementias in Look AHEAD | NIH | National Institute on Aging | 2021 to 2025 | $7,592,411 | August 15, 2021 | May 31, 2027 | UDEH-MOMOH, CHINEDU THERESA | reporter.nih.gov |
| Genotyping the Understanding America Study to generate novel opportunities for research on cognitive functioning and dementia | NIH | National Institute on Aging | 2023 to 2025 | $7,564,979 | September 15, 2023 | May 31, 2028 | GALAMA, TITUS JOHANNES | reporter.nih.gov |
| THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITE(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, STORE, CURATE, PRESERVE, AND | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,530,975 | May 1, 2025 | October 31, 2025 | SCOTT, WILLIAM | reporter.nih.gov |
| Parkinsons Disease Scalable iPSC Autologous Cell Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $7,528,144 | January 1, 2020 | December 31, 2025 | HALLETT, PENELOPE JANE | reporter.nih.gov |
| A major contributor of serious multisystem disease in the elderly: varicella zoster virus-induced inflammation | NIH | National Institute on Aging | 2021 to 2023 | $7,526,233 | March 1, 2009 | December 31, 2025 | NAGEL, MARIA ACENA | reporter.nih.gov |
| Plasma Proteomic Signatures for Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2022 | $7,523,227 | September 15, 2022 | August 31, 2025 | SHADYAB, ALADDIN | reporter.nih.gov |
| REpeated ASseSsmEnt of SurvivorS in ICH (REASSESS ICH) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $7,516,765 | January 1, 2022 | December 31, 2027 | ZIAI, WENDY C | reporter.nih.gov |
| Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,505,536 | September 1, 2021 | July 31, 2027 | DAUBERT, MELISSA | reporter.nih.gov |
| Indigenous Cultural Understandings of Alzheimer's Disease and Related Dementias - Research and Engagement (I-CARE) | NIH | National Institute on Aging | 2021 to 2025 | $7,489,463 | March 1, 2021 | February 28, 2027 | JACKLIN, KRISTEN | reporter.nih.gov |
| Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2024 | $7,486,964 | February 15, 2020 | January 31, 2026 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis | NIH | National Institute on Aging | 2021 to 2025 | $7,422,310 | September 20, 2024 | May 31, 2027 | LEWIS, GEORGE KENNETH | reporter.nih.gov |
| A randomized, placebo-controlled, double-blind study to evaluate safety and efficacy of NDX-1017 treatment in Alzheimer's dementia patients | NIH | National Institute on Aging | 2021 to 2022 | $7,416,643 | September 15, 2020 | May 31, 2023 | MOEBIUS, HANS JOERG | reporter.nih.gov |
| Multidimensional Assessment of Brain Health as A Marker of Dementia Risk and Resilience | NIH | National Institute on Aging | 2021 to 2024 | $7,413,273 | September 15, 2020 | May 31, 2025 | SESHADRI, SUDHA | reporter.nih.gov |
| Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) | NIH | National Institute on Aging | 2023 to 2024 | $7,403,993 | September 1, 2023 | August 31, 2028 | STONE, KATIE L | reporter.nih.gov |
| CYCLE-AD: Randomized Controlled Trial to Assess the Efficacy of Indoor Cycling in Slowing Disease Progression in Healthy Older Persons at Genetic Risk for Alzheimers Disease | NIH | National Institute on Aging | 2021 to 2025 | $7,389,501 | January 15, 2021 | December 31, 2026 | RAO, STEPHEN MARK | reporter.nih.gov |
| Therapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders | NIH | National Institute on Aging | 2021 to 2025 | $7,375,647 | July 1, 2021 | December 31, 2026 | REITZ, ALLEN BERNARD | reporter.nih.gov |
| Predictors of Altered CNS Structure, Function, and Connectomics in the Elderly using a Health Disparities Framework | NIH | National Institute on Aging | 2022 to 2025 | $7,350,257 | February 15, 2022 | November 30, 2027 | COHEN, ANN D. | reporter.nih.gov |
| IGF::OT::IGFEMMES NEIS-V | NIH | Office of the Director, National Institutes of Health | 2021 | $7,315,897 | November 1, 2016 | October 31, 2021 | HAMMEL, KERI | reporter.nih.gov |
| Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS II) | NIH | National Institute on Aging | 2024 to 2025 | $7,286,036 | June 15, 2024 | November 30, 2029 | JOHNSON-AKEJU, OLUWASEUN | reporter.nih.gov |
| Leveraging the 24-hour movement paradigm to preserve cognitive function and prevent Alzheimer's disease: The Multi-Ethnic Study of Atherosclerosis (MESA) 24H-ACT Study | NIH | National Institute on Aging | 2021 to 2024 | $7,263,372 | May 1, 2021 | April 30, 2026 | DIAZ, KEITH M | reporter.nih.gov |
| The VETSA Longitudinal MRI Twin Study of Aging (VETSA MRI 4) | NIH | National Institute on Aging | 2022 to 2025 | $7,252,240 | June 1, 2022 | March 31, 2027 | ELMAN, JEREMY A | reporter.nih.gov |
| Identification and Characterization of Cell-Specific Transposable Elements Implicated on Alzheimer Disease and Healthy Aging | NIH | National Institute on Aging | 2022 to 2025 | $7,239,829 | August 15, 2022 | June 30, 2027 | CRUCHAGA, CARLOS | reporter.nih.gov |
| SUBPOPULATIONS AND INTERMEDIATE OUTCOMES IN COPD (SPIROMICS) III | NIH | National Heart, Lung, and Blood Institute | 2025 | $7,234,660 | July 25, 2025 | July 24, 2026 | WOODRUFF, PRESCOTT G | reporter.nih.gov |
| Interventions Testing Program at UM | NIH | National Institute on Aging | 2021 to 2025 | $7,195,632 | July 1, 2003 | May 31, 2029 | MILLER, RICHARD A | reporter.nih.gov |
| Facility Upgrade for the New England Regional Biosafety Laboratory | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $7,162,679 | August 22, 2022 | February 28, 2025 | TELFORD, SAM R | reporter.nih.gov |
| Aging eyes and aging brains in studying alzheimer''s disease: Modern ophthalmic data collection in the adult changes in thought (ACT) study | NIH | National Institute on Aging | 2025 | $7,155,353 | September 1, 2019 | April 30, 2029 | LEE, CECILIA SUNGMIN | reporter.nih.gov |
| Genetics of deep-learning-derived neuroimaging endophenotypes for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $7,153,018 | July 1, 2021 | June 30, 2027 | ZHI, DEGUI | reporter.nih.gov |
| Neuroplasticity-Based Computerized Cognitive Remediation (nCCR) for Treatment Resistant Late-Life Depression | NIH | National Institute of Mental Health | 2021 to 2025 | $7,151,191 | April 15, 2021 | February 28, 2027 | MORIMOTO, SARAH SHIZUKO | reporter.nih.gov |
| Escitalopram for Agitation in Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2022 | $7,145,681 | September 30, 2016 | May 31, 2024 | LYKETSOS, CONSTANTINE G | reporter.nih.gov |
| Adjuvant Development of the TLR4 Ligand BECC470s For Use in Influenza, S. aureus, and P. aeruginosa Vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $7,143,498 | September 30, 2023 | September 29, 2028 | SORENSON, GREGORY | reporter.nih.gov |
| Action for Health in Diabetes (Look AHEAD) Extended Follow-up (LA-E2) | NIH | National Institute on Aging | 2021 to 2025 | $7,064,037 | August 1, 2021 | July 31, 2027 | ESPELAND, MARK ANDREW | reporter.nih.gov |
| Developing a NAMPT activator for Alzheimer’s disease | NIH | National Institute on Aging | 2023 to 2025 | $7,056,557 | September 15, 2023 | August 31, 2028 | CHEN, BEIBEI | reporter.nih.gov |
| Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2023 | $7,036,460 | September 15, 2019 | May 31, 2025 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Pan-Organ Spatial Atlas of Immunosenescence: Decoding Immune Aging Across Tissues and Scales | NIH | National Institute on Aging | 2021 to 2025 | $7,000,000 | September 30, 2021 | August 31, 2026 | FAN, RONG | reporter.nih.gov |
| Multi-arm Optimization of Stroke Thrombolysis (MOST) Stroke Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $6,997,609 | May 1, 2021 | October 31, 2024 | ADEOYE, OPEOLU M | reporter.nih.gov |
| Integrating the exposome and methylome to inform brain molecular changes in ADRD across established diverse cohorts. | NIH | National Institute on Aging | 2021 to 2022 | $6,989,910 | September 1, 2020 | August 31, 2025 | ERTEKIN-TANER, NILUFER | reporter.nih.gov |
| The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE) | NIH | National Institute on Aging | 2021 to 2024 | $6,976,066 | July 1, 2020 | June 30, 2025 | CHENG, SUSAN | reporter.nih.gov |
| University of Maryland Claude D. Pepper Older Americans Independence Center (OAIC) | NIH | National Institute on Aging | 2021 to 2025 | $6,970,364 | September 15, 2006 | June 30, 2027 | RYAN, ALICE S. | reporter.nih.gov |
| SELECTION, PRODUCTION, CHARACTERIZATION AND DISTRIBUTION OF CULTURED CELLS FOR RESEARCH ON AGING; PERIOD OF PERFORMANCE | NIH | National Institute on Drug Abuse | 2021 to 2024 | $6,965,174 | February 1, 2020 | January 31, 2025 | NORA, ENGEL | reporter.nih.gov |
| UCSF Older Americans Independence Center | NIH | National Institute on Aging | 2021 to 2025 | $6,946,581 | July 15, 2013 | June 30, 2028 | COVINSKY, KENNETH E. | reporter.nih.gov |
| Multidimensional mapping of vulnerable cell types in humanized Alzheimer's disease mouse models | NIH | National Institute on Aging | 2023 to 2025 | $6,945,316 | July 1, 2023 | March 31, 2028 | COBOS, INMA | reporter.nih.gov |
| Impact of Cannabinoid Across the Lifespan (ICAL) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $6,925,926 | July 1, 2018 | April 30, 2029 | PIOMELLI, DANIELE | reporter.nih.gov |
| Differential Effects of Exercise Modality on Cognition and Brain in Older Adults | NIH | National Institute on Aging | 2021 to 2025 | $6,923,080 | April 1, 2021 | March 31, 2027 | VIDONI, ERIC DENNIS | reporter.nih.gov |
| Whole Individual Comprehensive KnowlEDge: Somatic Mosaicism across Human Tissues (WICKed SMaHT) | NIH | National Institute on Drug Abuse | 2023 to 2025 | $6,922,231 | May 1, 2023 | April 30, 2026 | ARDLIE, KRISTIN | reporter.nih.gov |
| Risk Factors for Future Cognitive Decline and Alzheimers Disease in Older African Americans | NIH | National Institute on Aging | 2021 to 2025 | $6,919,789 | May 15, 2018 | May 31, 2028 | GLUCK, MARK A | reporter.nih.gov |
| Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2025 | $6,908,458 | July 15, 2021 | June 30, 2027 | VANCE, JEFFERY MARVIN | reporter.nih.gov |
| Lifetime stressors and Alzheimer's Disease genetic variants and biomarkers in relation to cognitive decline among Black Women'sHealth Study participants. | NIH | National Institute on Aging | 2024 to 2025 | $6,906,113 | February 15, 2024 | January 31, 2029 | ROSENBERG, LYNN | reporter.nih.gov |
| Toward Healthy Aging in Adults with Autism: A Longitudinal Clinical and Multimodal Brain Imaging Study | NIH | National Institute of Mental Health | 2022 to 2024 | $6,900,037 | September 6, 2022 | June 30, 2027 | LAINHART, JANET ELIZABETH | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,882,445 | September 29, 2025 | September 28, 2026 | WACTAWSKI-WENDE, JEAN | reporter.nih.gov |
| Clinical trials to prevent Alzheimer's Disease in Down Syndrome | NIH | National Institute on Aging | 2022 to 2024 | $6,863,895 | September 15, 2019 | August 31, 2025 | RAFII, MICHAEL S | reporter.nih.gov |
| GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $6,827,181 | June 1, 2022 | May 31, 2027 | WATTERSON, DANIEL MARTIN | reporter.nih.gov |
| Precision phenotyping of emphysema in the elderly: the MESA Lung Study | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,794,185 | August 2, 2004 | January 31, 2027 | BARR, R GRAHAM | reporter.nih.gov |
| The adaptive-innate immune interactome across multiple tissues in Alzheimer's disease | NIH | National Institute on Aging | 2023 to 2025 | $6,770,771 | May 15, 2023 | January 31, 2028 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Examining the Persistence of Neurocognitive Benefits of Exercise | NIH | National Institute on Aging | 2023 to 2025 | $6,759,799 | September 1, 2023 | May 31, 2028 | ERICKSON, KIRK I | reporter.nih.gov |
| Artificial Intelligence Strategies for Alzheimer's Disease Research | NIH | National Institute on Aging | 2022 to 2025 | $6,749,268 | September 30, 2021 | August 31, 2026 | MOORE, JASON H. | reporter.nih.gov |
| North Carolina Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,742,732 | April 7, 2020 | May 31, 2028 | NEUFER, P DARRELL | reporter.nih.gov |
| Adapting the ShedMEDS Deprescribing Intervention to Dementia Care in Assisted Living | NIH | National Institute on Aging | 2021 to 2023 | $6,628,141 | August 15, 2019 | July 31, 2024 | STEINMAN, MICHAEL A. | reporter.nih.gov |
| Developing Novel Soluble Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2024 | $6,621,893 | September 15, 2020 | May 31, 2026 | WANG, JIN | reporter.nih.gov |
| Cell Specific Perturbations of the Proteome in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $6,610,744 | September 30, 2021 | July 31, 2027 | YATES III, JOHN R | reporter.nih.gov |
| Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $6,609,782 | September 30, 2014 | August 31, 2030 | BENATAR, MICHAEL | reporter.nih.gov |
| Leveraging an ongoing longitudinal study of influenza vaccination to define immune signatures of response and risk of infection in older adults >75 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $6,605,926 | December 9, 2021 | November 30, 2026 | LENG, SEAN XIAO | reporter.nih.gov |
| A Pragmatic Trial of the UCSF Brain Health Assessment for the Detection of Cognitive Impairment in Primary Care | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $6,593,404 | September 15, 2022 | August 31, 2027 | POSSIN, KATHERINE LAUREL | reporter.nih.gov |
| Precision Editing of Granulin Mutations that Cause Frontotemporal Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $6,580,415 | August 15, 2025 | July 31, 2029 | SONTHEIMER, ERIK J. | reporter.nih.gov |
| Life-course social adversity, pesticide exposure, and cognitive outcomes among an ongoing cohort of mid-life Latina women in an under served agricultural region | NIH | National Institute on Aging | 2021 to 2024 | $6,569,013 | September 15, 2020 | May 31, 2026 | TORRES, JACQUELINE MARIE | reporter.nih.gov |
| BIOLOGICAL SPECIMENS' RECEIPT, STORAGE, MANAGEMENT AND DISTRIBUTION | NIH | National Institute on Drug Abuse | 2023 to 2025 | $6,564,413 | July 30, 2023 | July 29, 2025 | LANGENBACH, KURT | reporter.nih.gov |
| Dementia with Lewy Bodies Consortium | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $6,563,373 | September 30, 2016 | August 31, 2027 | LEVERENZ, JAMES BRUCE | reporter.nih.gov |
| Technology to Realize the Full Potential of UHF MRI | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $6,553,989 | February 1, 2019 | January 31, 2029 | METZGER, GREGORY JOHN | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,534,889 | September 29, 2025 | September 28, 2026 | STEFANICK, MARCIA | reporter.nih.gov |
| The RAW Brain - The Effect of Rumination, Anxiety and Worry on Aging and Dementia Risk | NIH | National Institute of Mental Health | 2021 to 2025 | $6,507,641 | September 20, 2016 | June 30, 2027 | ANDREESCU, CARMEN | reporter.nih.gov |
| Novel therapy for alcoholic liver disease-associated hepatorenal syndrome | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $6,485,223 | September 25, 2021 | August 31, 2027 | SUBRAMANIAN, MANI | reporter.nih.gov |
| The effects of Alzheimer's disease risk genes on metabolism and signaling across cell types | NIH | National Institute on Aging | 2022 to 2025 | $6,477,664 | September 19, 2022 | August 31, 2027 | FRAENKEL, ERNEST | reporter.nih.gov |
| Whole Person Reference Physiome Research and Coordination Center | NIH | National Center for Complementary & Integrative Health | 2025 | $6,476,031 | August 8, 2025 | July 31, 2028 | SNYDER, MICHAEL P. | reporter.nih.gov |
| Extracranial Carotid Atherosclerosis Contributions to Cognitive Impairment and Alzheimer's Disease Risk | NIH | National Institute on Aging | 2021 to 2025 | $6,475,434 | August 15, 2021 | May 31, 2027 | WEINKAUF, CRAIG C | reporter.nih.gov |
| Multigenerational Longitudinal Panel for Research on Aging | NIH | National Institute on Aging | 2021 to 2025 | $6,471,371 | September 1, 2018 | May 31, 2029 | RUGGLES, STEVE | reporter.nih.gov |
| The Ante-Amyloid Treatment of Alzheimer's disease (A3) Trial and Alzheimer Plasma EXtension (APEX) Study | NIH | National Institute on Aging | 2025 | $6,467,513 | September 1, 2025 | August 31, 2030 | SPERLING, REISA A. | reporter.nih.gov |
| The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study | NIH | National Institute on Aging | 2021 to 2024 | $6,442,962 | June 15, 2020 | March 31, 2025 | VERGHESE, JOE | reporter.nih.gov |
| Trends and Dynamics in Caregiving for Alzheimer’s Disease and Related Dementias: Extending the National Study of Caregiving | NIH | National Institute on Aging | 2021 to 2023 | $6,436,858 | June 15, 2019 | May 31, 2026 | FREEDMAN, VICKI A. | reporter.nih.gov |
| Moderation of Aging Trajectories of Cognition and Neuropathology by Diet Composition in Middle-aged Nonhuman Primates | NIH | National Institute on Aging | 2025 | $6,424,607 | September 15, 2025 | September 14, 2029 | BAXTER, MARK G | reporter.nih.gov |
| Contributions of stress reactivity to risk of Alzheimer's disease and related dementia's in a community-based cohort | NIH | National Institute on Aging | 2021 to 2025 | $6,416,931 | September 30, 2021 | May 31, 2027 | KERSHAW, KIARRI N | reporter.nih.gov |
| 2/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study) | NIH | National Institute of Mental Health | 2021 to 2024 | $6,409,923 | September 1, 2020 | June 30, 2026 | TAYLOR, WARREN D | reporter.nih.gov |
| Metals and Metal Mixtures: Cognitive Aging, Remediation and Exposure Sources (MEMCARE) | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $6,396,550 | February 21, 2020 | May 9, 2025 | LU, QUAN | reporter.nih.gov |
| Validation of the Remote Cognitive Aging and Alzheimer’s Disease REsearch (R-CARE) Toolbox for Diverse Populations | NIH | National Institute on Aging | 2023 to 2025 | $6,381,700 | August 15, 2023 | May 31, 2028 | LIPTON, RICHARD B. | reporter.nih.gov |
| CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan | NIH | National Cancer Institute | 2023 to 2025 | $6,381,605 | September 22, 2021 | August 31, 2027 | FRIEDMAN, DEBRA L. | reporter.nih.gov |
| Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL | NIH | National Institute on Aging | 2022 to 2025 | $6,381,039 | September 1, 2022 | May 31, 2027 | HAINES, JONATHAN L | reporter.nih.gov |
| DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $6,359,752 | September 30, 2023 | September 29, 2028 | LAPEK, JENNIFER | reporter.nih.gov |
| Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2024 | $6,353,055 | May 15, 2020 | April 30, 2026 | TSAI, LI-HUEI | reporter.nih.gov |
| Cerebral small vessel disease burden and racial disparity in vascular cognitive impairment and Alzheimer’s disease and its related dementias | NIH | National Institute on Aging | 2021 to 2025 | $6,336,090 | September 15, 2021 | May 31, 2027 | HYACINTH, HYACINTH IDU | reporter.nih.gov |
| The spectrum of cognitive impairment including Alzheimer’s Disease and Related Dementias after liver transplantation | NIH | National Institute on Aging | 2021 to 2025 | $6,330,805 | June 15, 2018 | May 31, 2028 | LAI, JENNIFER C. | reporter.nih.gov |
| A Life Course Approach to Integrating Trauma and Cognitive Aging: A Cohort of 9/11 Responders | NIH | National Institute on Aging | 2021 to 2024 | $6,329,240 | May 15, 2015 | April 30, 2026 | CLOUSTON, SEAN | reporter.nih.gov |
| The HIV and Alcohol Research center focused on Polypharmacy (HARP) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $6,323,238 | September 10, 2021 | August 31, 2026 | JUSTICE, AMY CAROLINE | reporter.nih.gov |
| Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $6,313,088 | September 30, 2021 | August 31, 2026 | ZAIDI, MONE | reporter.nih.gov |
| Risk and Resilience, Clinical presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The DIAGNOSE CTE Research Project II | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $6,308,426 | August 15, 2024 | July 31, 2029 | ALOSCO, MICHAEL | reporter.nih.gov |
| Mentoring Research Excellence in Aging and Regenerative Medicine | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $6,297,053 | June 1, 2022 | May 31, 2027 | JAZWINSKI, S MICHAL | reporter.nih.gov |
| PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial | NIH | National Institute on Aging | 2022 to 2025 | $6,295,083 | February 15, 2022 | January 31, 2027 | BRINTON, ROBERTA EILEEN | reporter.nih.gov |
| Phase II trial of GM-CSF/sargramostim in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2023 | $6,265,868 | February 1, 2021 | November 30, 2026 | POTTER, HUNTINGTON | reporter.nih.gov |
| The NH Explanatory Trials Network: Supporting Transformation by Enhancing Partnerships (The NEXT STEPS). | NIH | National Institute on Aging | 2024 to 2025 | $6,261,370 | September 1, 2024 | May 31, 2029 | UNROE, KATHLEEN T | reporter.nih.gov |
| Cortical basis of complex motor sequences in humans for neural interfaces | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $6,260,537 | September 22, 2021 | August 31, 2026 | HENDERSON, JAIMIE M | reporter.nih.gov |
| Validation of Biomarkers of Small Vessel Injury in VCID | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $6,258,167 | September 29, 2021 | July 31, 2026 | ROSENBERG, GARY ALLEN | reporter.nih.gov |
| Longitudinal Examination of Neighborhood Disadvantage, Cognitive Aging, and Alzheimer's Disease Risk in Disinvested, African American Neighborhoods | NIH | National Institute on Aging | 2022 to 2024 | $6,229,431 | February 15, 2022 | January 31, 2025 | DUBOWITZ, TAMARA | reporter.nih.gov |
| BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIA | NIH | National Cancer Institute | 2022 to 2024 | $6,227,249 | June 15, 2022 | May 15, 2025 | CLAPPER, MARGIE L. | reporter.nih.gov |
| Washington University University of Texas Southwestern VCID Consortium Site | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $6,224,729 | September 29, 2021 | July 31, 2026 | LEE, JIN-MOO | reporter.nih.gov |
| Objective Physical Activity and Cardiovascular Health in Older Women: OPACH2 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,198,164 | August 15, 2022 | June 30, 2027 | LACROIX, ANDREA Z. | reporter.nih.gov |
| IND Enabling Studies for a Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Alzheimer's Disease Related Dementia | NIH | National Institute on Aging | 2021 to 2023 | $6,168,197 | April 15, 2020 | March 31, 2024 | HAY, MEREDITH | reporter.nih.gov |
| Traumatic Brain Injury and Repetitive Head Impacts: Contributions to AD/ADRD and CTE Neuropathology and Resulting Clinical Syndromes | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $6,142,337 | September 30, 2019 | July 31, 2025 | MCKEE, ANN C. | reporter.nih.gov |
| Scheduled Prophylactic 6-hourly IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients (PANDORA) - Administrative Supplement | NIH | National Institute on Aging | 2021 to 2025 | $6,139,069 | September 30, 2019 | November 30, 2026 | SUBRAMANIAM, BALACHUNDHAR | reporter.nih.gov |
| Imaging Genetics of Brain Structure and Cognitive Aging in Murine Models of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $6,121,279 | February 1, 2021 | January 31, 2027 | WILLIAMS, ROBERT W. | reporter.nih.gov |
| The University of Kentucky MarkVCID Biomarker Validation Cohort: Development of a Toolbox to Advance VCID Interventional Studies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $6,120,000 | September 29, 2021 | July 31, 2026 | JICHA, GREGORY A | reporter.nih.gov |
| Elucidate the roles of Alzheimer's disease risk genes and variants in gene expression and AD-related phenotypes | NIH | National Institute on Aging | 2022 to 2025 | $6,109,739 | September 15, 2022 | August 31, 2027 | SHEN, YIN | reporter.nih.gov |
| Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE) | NIH | National Cancer Institute | 2021 to 2023 | $6,108,355 | April 15, 2018 | March 31, 2025 | CORLEY, DOUGLAS ALLEN | reporter.nih.gov |
| Establishing the science behind Alzheimer's recruitment registries: opportunities for increasing diversity and accelerating enrollment into trials | NIH | National Institute on Aging | 2021 to 2023 | $6,105,662 | September 1, 2019 | March 21, 2025 | LANGBAUM, JESSICA BROOKE | reporter.nih.gov |
| MarkVCID Validation in the General Community | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $6,100,999 | September 23, 2021 | July 31, 2026 | PETERSEN, RONALD C | reporter.nih.gov |
| BackInAction Administrative Supplement | NIH | National Center for Complementary & Integrative Health | 2021 to 2022 | $6,098,263 | September 28, 2019 | August 31, 2025 | DEBAR, LYNN L. | reporter.nih.gov |
| Single-cell transcriptomic and epigenomic analysis of brain cell vulnerabilities to tauopathies in early AD impacted brain regions | NIH | National Institute on Aging | 2023 to 2025 | $6,093,858 | June 1, 2023 | February 29, 2028 | XU, XIANGMIN | reporter.nih.gov |
| Metabolic effects and mechanisms for heart failure in South Asians | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,092,913 | June 7, 2021 | May 31, 2027 | KANAYA, ALKA M. | reporter.nih.gov |
| Long-Term Nicotine Treatment of Mild Cognitive Impairment | NIH | National Institute on Aging | 2022 | $6,088,879 | September 15, 2015 | January 31, 2026 | NEWHOUSE, PAUL A. | reporter.nih.gov |
| Biomarker Evaluation in Young Onset Dementia from Diverse Populations (BEYONDD) | NIH | National Institute on Aging | 2022 | $6,065,228 | September 15, 2022 | August 31, 2025 | BOXER, ADAM L. | reporter.nih.gov |
| CNS Mechanisms Linking Exercise Training with Energy Balance and Metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $6,058,407 | September 20, 2019 | August 31, 2025 | ELMQUIST, JOEL K. | reporter.nih.gov |
| Diagnosis and Risk factors of hippocampal sclerosis of aging and limbic predominant age related TDP-43 encephalopathy; common Alzheimer’s mimics | NIH | National Institute on Aging | 2021 to 2025 | $6,052,469 | April 1, 2019 | May 31, 2029 | SAJJADI, SEYED AHMAD | reporter.nih.gov |
| Effectiveness of Implementing an Intensive Blood Pressure Reduction Intervention on Cognitive Decline in Low-income and Minority Hypertensive Patients | NIH | National Institute on Aging | 2021 to 2024 | $6,046,063 | August 1, 2020 | July 31, 2025 | MILLS, KATHERINE TERESA | reporter.nih.gov |
| 2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,043,000 | August 25, 2022 | July 31, 2029 | HANLEY, DANIEL F | reporter.nih.gov |
| Delirium, Dementia, and the Vulnerable Brain: An Integrative Approach | NIH | National Institute on Aging | 2021 to 2022 | $6,002,449 | September 15, 2018 | May 31, 2024 | INOUYE, SHARON K. | reporter.nih.gov |
| Decoding the impact of sex differences on Alzheimer's disease risk | NIH | National Institute on Aging | 2021 to 2025 | $5,985,073 | September 15, 2021 | June 30, 2027 | LICHTARGE, OLIVIER | reporter.nih.gov |
| Randomized Trial of Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients | NIH | National Institute on Aging | 2022 to 2025 | $5,979,214 | August 1, 2022 | June 30, 2027 | ROTHBERG, MICHAEL B | reporter.nih.gov |
| Development of novel NLRP3 inflammasome inhibitors for intervening in Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $5,966,043 | June 1, 2022 | May 31, 2027 | ZHANG, SHIJUN | reporter.nih.gov |
| Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum | NIH | National Institute on Aging | 2021 to 2025 | $5,959,465 | September 15, 2021 | May 31, 2027 | CHIOSIS, GABRIELA | reporter.nih.gov |
| VCID CWOW: Identifying Novel Targets to Treat Cerebral Amyloid Angiopathy | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $5,949,022 | September 18, 2024 | August 31, 2027 | HOWELL, GARETH R | reporter.nih.gov |
| Integration of immune cell subtypes across diseases & tissue | NIH | National Institute on Aging | 2021 to 2022 | $5,948,190 | September 30, 2018 | August 31, 2023 | DE JAGER, PHILIP L | reporter.nih.gov |
| URBAn Native Elders (URBANE): Risk and Protective Factors for Alzheimer's and Related Dementias | NIH | National Institute on Aging | 2021 to 2024 | $5,941,036 | September 1, 2019 | May 31, 2026 | NELSON, LONNIE A. | reporter.nih.gov |
| San Antonio Nathan Shock Center of Excellence in the Biology of Aging | NIH | National Institute on Aging | 2021 to 2025 | $5,933,619 | July 15, 1997 | May 31, 2030 | SALMON, ADAM | reporter.nih.gov |
| Dissecting the role of sex-linked genes and APOE e4 risk in AD | NIH | National Institute on Aging | 2021 to 2025 | $5,928,484 | September 30, 2021 | July 31, 2027 | YOUNG, JESSICA ELAINE | reporter.nih.gov |
| Chaperome networks in Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2025 | $5,927,093 | February 15, 2021 | January 31, 2027 | CHIOSIS, GABRIELA | reporter.nih.gov |
| Penn PET Addiction Center of Excellence (PACE) | NIH | National Institute on Drug Abuse | 2021 to 2023 | $5,914,143 | August 15, 2019 | June 30, 2025 | MACH, ROBERT H | reporter.nih.gov |
| Proteostasis in Aging and Neurodegenerative Disease | NIH | National Institute on Aging | 2021 to 2022 | $5,911,869 | September 30, 2018 | May 31, 2024 | MORIMOTO, RICHARD I | reporter.nih.gov |
| THE PURPOSE OF THIS TASK ORDER IS TO PROVIDE THE NATIONAL INSTITUTE ON AGING WITH INFORMATION RESOURCE CENTER SERVICES IN ACCORDANCE WITH THE ATTACHED STATEMENT OF WORK AND QUOTE DATED 8/1/2025. | NIH | National Institute on Drug Abuse | 2024 to 2025 | $5,908,784 | September 16, 2025 | September 15, 2026 | reporter.nih.gov | |
| PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: an FDA required Toxicology Study | NIH | National Institute on Aging | 2023 to 2025 | $5,906,221 | September 1, 2023 | August 31, 2027 | HAY, MEREDITH | reporter.nih.gov |
| Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2022 to 2025 | $5,896,816 | August 15, 2022 | May 31, 2027 | KANTHASAMY, ANUMANTHA GOUNDER | reporter.nih.gov |
| Late-onset Unexplained Epilepsy as a Risk Factor for Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $5,883,988 | September 1, 2023 | February 28, 2029 | LAM, ALICE D | reporter.nih.gov |
| Comparison of Hemorrhagic & Ischemic Stroke Among Blacks and Whites | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $5,858,736 | September 22, 1992 | June 30, 2026 | KISSELA, BRETT M | reporter.nih.gov |
| Advancing the Science and Practice of Ecological Momentary Assessment | NIH | National Institute on Aging | 2021 to 2025 | $5,835,222 | April 1, 2024 | March 31, 2029 | STONE, ARTHUR A | reporter.nih.gov |
| Clinical trial of omalizumab for allergen sensitized and exposed individuals with COPD | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $5,833,457 | August 15, 2024 | May 31, 2031 | PUTCHA, NIRUPAMA | reporter.nih.gov |
| A Proteomic Comparison of Sporadic Early-Onset, Late-Onset, and Autosomal Dominant Alzheimer's Disease | NIH | National Institute on Aging | 2024 to 2025 | $5,825,826 | September 30, 2024 | July 31, 2029 | JOHNSON, ERIK C.B. | reporter.nih.gov |
| Bloomington Drosophila Stock Center at Indiana University | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $5,798,879 | August 15, 2014 | July 31, 2029 | COOK, KEVIN R | reporter.nih.gov |
| Study of Latinos (SOL) Ojos | NIH | National Eye Institute | 2021 to 2023 | $5,789,999 | September 1, 2019 | July 31, 2025 | JOSLIN, CHARLOTTE E | reporter.nih.gov |
| Examining Effects of Intensive BP Control on MCI/Dementia and Plasma Biomarker Trajectories by AD Pathology: Elucidating neuroprotective effects in the racially and ethnically diverse SPRINT trial | NIH | National Institute on Aging | 2025 | $5,789,766 | September 30, 2025 | June 30, 2030 | BRESS, ADAM P | reporter.nih.gov |
| VCID and Stroke in a Bi-racial National Cohort | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $5,761,773 | September 24, 2001 | September 16, 2024 | JUDD, SUZANNE E | reporter.nih.gov |
| Columbia University Science of Behavior Change Resource and Coordinating Center renewal | NIH | National Institute on Aging | 2021 to 2024 | $5,758,737 | September 30, 2015 | August 31, 2025 | EDMONDSON, DONALD | reporter.nih.gov |
| First-in-Human (Phase 1) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of IBC-Ab002 in Persons with Early Alzheimer's Disease (AD) | NIH | National Institute on Aging | 2021 to 2023 | $5,749,685 | September 1, 2021 | August 31, 2024 | YOLES, ETI | reporter.nih.gov |
| Genetic models of sporadic Alzheimers Disease in the marmoset | NIH | National Institute on Aging | 2021 to 2024 | $5,749,378 | September 1, 2021 | June 30, 2026 | LEE, KUO-FEN | reporter.nih.gov |
| The Alzheimer Disease Sequence Analysis Collaborative | NIH | National Institute on Aging | 2021 to 2022 | $5,746,500 | September 30, 2018 | August 31, 2025 | HAINES, JONATHAN L | reporter.nih.gov |
| Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease | NIH | National Institute on Drug Abuse | 2021 to 2024 | $5,744,264 | June 1, 2016 | April 30, 2025 | LAI, SHENGHAN | reporter.nih.gov |
| Discovery of Drugs that Modulate Neuroinflammation for the treatment of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2024 | $5,740,022 | June 15, 2021 | May 31, 2026 | HODGETTS, KEVIN | reporter.nih.gov |
| Cerebral tau deposition and comorbid cerebrovascular disease across the Alzheimer's disease continuum in Mexican Americans | NIH | National Institute on Aging | 2024 to 2025 | $5,730,361 | August 15, 2024 | August 31, 2029 | HABES, MOHAMAD | reporter.nih.gov |
| Oklahoma Nathan Shock Center of Excellence in Basic Biology of Aging | NIH | National Institute on Aging | 2021 to 2025 | $5,706,618 | July 15, 2015 | May 31, 2030 | GALVAN, VERONICA | reporter.nih.gov |
| NPTX2: Preserving memory circuits in normative aging and Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $5,697,103 | May 1, 2021 | April 30, 2027 | BARNES, CAROL A. | reporter.nih.gov |
| Brain pathologies, reserve and cognition in aging and dementia | NIH | National Institute on Aging | 2022 to 2025 | $5,694,414 | March 1, 2009 | March 31, 2027 | TOMASZEWSKI-FARIAS, SARAH E | reporter.nih.gov |
| A Single Ascending Dose / Multiple Ascending Dose Phase I study of the GSM 776890 in healthy normal subjects | NIH | National Institute on Aging | 2021 to 2022 | $5,678,762 | February 1, 2021 | May 31, 2024 | GALASKO, DOUGLAS R | reporter.nih.gov |
| NBER Center for Aging and Health Research | NIH | National Institute on Aging | 2021 to 2025 | $5,663,258 | August 1, 1997 | August 31, 2027 | CUTLER, DAVID M | reporter.nih.gov |
| Earlier-Life Predictors of Midlife Risk Factors for Dementia: A 35-Year Follow-up (Revision) | NIH | National Institute on Aging | 2023 to 2025 | $5,646,724 | March 1, 2023 | February 29, 2028 | REBOK, GEORGE W. | reporter.nih.gov |
| Identifying resilience proteins in key motor tissues that drive motor and cognitive decline and offset the negative effects of ADRD pathologies within and outside the brain | NIH | National Institute on Aging | 2022 to 2025 | $5,619,647 | April 1, 2022 | January 31, 2027 | BUCHMAN, ARON S | reporter.nih.gov |
| Adversity, Aging and ADRD Risk among the Global Poor: A Biosocial Lifecourse Approach | NIH | National Institute on Aging | 2023 to 2025 | $5,604,169 | May 1, 2023 | February 28, 2029 | KOHLER, HANS-PETER | reporter.nih.gov |
| Exercise and Bisphosphonate Use to Minimize Weight Loss Associated Bone Loss among Older Adults | NIH | National Institute on Aging | 2022 to 2025 | $5,597,882 | September 1, 2022 | August 31, 2027 | BEAVERS, KRISTEN MARIE | reporter.nih.gov |
| Development of an Innovative Vervet (Chlorocebus aethiops sabaeus) Model of Early Alzheimer's-like Neuropathology and Symptomatology | NIH | National Institute on Aging | 2021 to 2024 | $5,592,774 | September 15, 2021 | May 31, 2026 | SHIVELY, CAROL A. | reporter.nih.gov |
| Influence of Dietary Botanical Supplements on Biological and Behavioral Resilience | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $5,585,106 | July 1, 2020 | June 30, 2026 | MURROUGH, JAMES WARREN | reporter.nih.gov |
| A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial | NIH | National Institute on Aging | 2021 to 2025 | $5,580,574 | September 1, 2021 | August 31, 2027 | MUREA, MARIANA | reporter.nih.gov |
| Atlas for neuronal and glial cell types selectively vulnerable to proteinopathies during progression of Alzheimer's Disease | NIH | National Institute on Aging | 2023 to 2024 | $5,580,121 | June 1, 2023 | February 28, 2029 | LEE, KUO-FEN | reporter.nih.gov |
| Early risk factors of accelerated neural aging trajectories and cognitive decline: a nonhuman primate longitudinal model | NIH | National Institute on Aging | 2021 to 2025 | $5,565,416 | August 1, 2021 | April 30, 2027 | SANCHEZ, MAR M | reporter.nih.gov |
| Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)-Genomic study | NIH | National Institute on Aging | 2021 to 2023 | $5,561,015 | September 15, 2019 | August 31, 2025 | LEE, JINKOOK | reporter.nih.gov |
| Interplay of Myocardial Fibrosis and Cardiac TTR Amyloid in Age Related Cardiac Remodeling in MESA-Multi-Ethnic Study of Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,552,808 | April 1, 2022 | March 31, 2027 | LIMA, JOAO A C | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Leidos Biomedical Research, Inc. | Frederick, MD | 1 | $2.96 billion | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 441 | $769.1 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 453 | $715.3 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 324 | $700 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 248 | $649 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 286 | $640.5 million | 0 | $0 |
| Washington University | Saint Louis, MO | 304 | $619 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 349 | $590.3 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 391 | $541.6 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 322 | $500.8 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 281 | $440.7 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 212 | $439 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 221 | $417.7 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 215 | $400.4 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 245 | $394.8 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 153 | $355.2 million | 0 | $0 |
| Duke University | Durham, NC | 247 | $339.2 million | 0 | $0 |
| Emory University | Atlanta, GA | 223 | $334.6 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 177 | $327.3 million | 0 | $0 |
| Stanford University | Stanford, CA | 258 | $317.2 million | 0 | $0 |
| Yale University | New Haven, CT | 230 | $308.4 million | 0 | $0 |
| University of Washington | Seattle, WA | 199 | $305.5 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 163 | $291.3 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 86 | $287.1 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 201 | $284.4 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 214 | $275.4 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 192 | $269.4 million | 0 | $0 |
| University of California at Davis | Davis, CA | 109 | $264.2 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 154 | $261.9 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 127 | $254.6 million | 0 | $0 |
| University of Florida | Gainesville, FL | 224 | $247.7 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 154 | $234.5 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 117 | $231.9 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 188 | $228.7 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 172 | $224.4 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 132 | $210.1 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 169 | $207 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 117 | $197.4 million | 0 | $0 |
| Brown University | Providence, RI | 109 | $195.7 million | 0 | $0 |
| Rush University Medical Center | Chicago, IL | 67 | $169.8 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 90 | $165 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 110 | $162.4 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 53 | $161.5 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 96 | $160.3 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 121 | $155.4 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 96 | $154.1 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 123 | $149.8 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 95 | $148.9 million | 0 | $0 |
| Northern California Institute/res/edu | San Francisco, CA | 30 | $140 million | 0 | $0 |
| Ohio State University | Columbus, OH | 126 | $127.3 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 100 | $119 million | 0 | $0 |
| University of Rochester | Rochester, NY | 118 | $116.4 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 90 | $115.5 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 75 | $109.3 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 108 | $108.2 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 104 | $107.6 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 83 | $107.4 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 88 | $105.8 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 59 | $105.3 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 64 | $104.7 million | 0 | $0 |
| University of South Florida | Tampa, FL | 71 | $104.6 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 65 | $103.3 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 68 | $100.3 million | 0 | $0 |
| Mayo Clinic Jacksonville | Jacksonville, FL | 52 | $98.5 million | 0 | $0 |
| Banner Health | Phoenix, AZ | 10 | $91.7 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 75 | $87.3 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 65 | $87.1 million | 0 | $0 |
| Cognition Therapeutics, Inc. | Pittsburgh, PA | 5 | $86.6 million | 0 | $0 |
| California Pacific Med CTR Res Institute | San Francisco, CA | 9 | $84.2 million | 0 | $0 |
| Buck Institute for Research on Aging | Novato, CA | 48 | $84 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 44 | $82.2 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 55 | $81.4 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 60 | $81.4 million | 0 | $0 |
| J. David Gladstone Institutes | San Francisco, CA | 44 | $80.6 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 87 | $79.8 million | 0 | $0 |
| Augusta University | Augusta, GA | 66 | $79.3 million | 0 | $0 |
| Georgetown University | Washington, DC | 52 | $77.4 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 25 | $76.5 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 46 | $74 million | 0 | $0 |
| University of Chicago | Chicago, IL | 62 | $73 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 79 | $72.9 million | 0 | $0 |
| University of Mississippi Med CTR | Jackson, MS | 19 | $72.6 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 39 | $71.2 million | 0 | $0 |
| Allen Institute | Seattle, WA | 4 | $70.8 million | 0 | $0 |
| Jackson Laboratory | Bar Harbor, ME | 44 | $69.2 million | 0 | $0 |
| Charles River Laboratories Intntl, Inc. | Wilmington, MA | 8 | $67.9 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 40 | $66.2 million | 0 | $0 |
| SUNY at Stony Brook | Stony Brook, NY | 49 | $62.5 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 35 | $60.1 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 52 | $59.6 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 50 | $59.4 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 61 | $56.8 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 20 | $56.4 million | 0 | $0 |
| University of North Texas HLTH Sci CTR | Fort Worth, TX | 19 | $56.3 million | 0 | $0 |
| Salk Institute for Biological Studies | La Jolla, CA | 24 | $56 million | 0 | $0 |
| Sanford Burnham Prebys Medical Discovery Institute | La Jolla, CA | 39 | $55.9 million | 0 | $0 |
| Harvard University | Cambridge, MA | 34 | $55 million | 0 | $0 |
| SUNY Downstate Medical Center | Brooklyn, NY | 8 | $54.3 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 34 | $53.5 million | 0 | $0 |
| University of Oklahoma HLTH Sciences CTR | Oklahoma City, OK | 51 | $53.3 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 6,593 | $5,429,873,993 | 0 | $0 |
| 2024 | 7,683 | $5,665,453,868 | 0 | $0 |
| 2023 | 7,709 | $6,053,120,146 | 0 | $0 |
| 2022 | 7,715 | $5,718,311,845 | 0 | $0 |
| 2021 | 7,545 | $5,492,751,486 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.